U.S. lagging on transradial PCI endangers patients

Article Type
Changed
Tue, 07/21/2020 - 14:14
Display Headline
U.S. lagging on transradial PCI endangers patients

Why are American cardiologists so far behind the worldwide curve in performing percutaneous coronary interventions by the radial-artery route?

The degree to which ACS patients suffer needlessly when they undergo percutaneous coronary intervention (PCI) via their femoral artery and not with transradial access was finally, definitively demonstrated in results from the MATRIX Access trial, presented earlier this week at the annual meeting of the American College of Cardiology. The MATRIX results showed in more than 8,000 patients that using a transradial approach for PCI was linked with a statistically significant improvement in 30-day patient survival, a 0.6% absolute difference. For every 167 patients treated by the transradial route, an additional patient lived, compared with similar patients treated with transfemoral access.

Dr. Roxana Mehran

The radial approach also cut serious access-site bleeding episodes by an absolute 0.7%, and it was this difference that appeared to mainly drive the difference in patient survival. As study discussant Dr. Roxana Mehran declared from the dais following the MATRIX report, “Bleeding matters! Here is where it’s been proven.”

Results from a second, unrelated trial reported at the meeting, TOTAL, showed that during 2010-2014, in more than 10,000 patients with ST-elevation myocardial infarction treated by PCI in 20 different countries, 68% of patients underwent their procedure via a transradial route.

In contrast, cardiologists I spoke with at the meeting said that recent estimates of PCI use by U.S. interventionalists indicated that they perform roughly 20% of PCIs transradially. That level substantially jumped over the past decade; 10 years ago U.S. transradial use stood at about 3% of all PCIs, my sources said. But 20% still lags woefully behind a worldwide rate of 68%, especially when access site can make a life-or-death difference.

Interventionalists at the meeting also told me some reasons why transfemoral access remains favored. First, it’s the approach many operators first trained in, so they are more familiar and comfortable with it. Second, transradial PCI can take longer, result in higher radiation exposure, and in some patients it’s simply impossible, which means crossover to transfemoral anyway. Finally, transfemoral PCI is just plain easier, they said.

Courtesy Wikipedia Commons/Henry Gray/Public Domain

Most of these reasons fall flat when contrasted with causing significantly fewer serious bleeds and improved survival. Of course, when transradial proves impossible there is no choice other than going with transfemoral, but as proponents of transradial said at the meeting, it is a matter of making transradial the initial, default strategy and only resorting to transfemoral when absolutely necessary.

The MATRIX results had another very important finding: To get the best outcomes, centers that offer PCI to acute coronary syndrome patients can’t simply dabble with the transradial approach; they need to be all in. A subanalysis of the MATRIX mortality benefit for transradial procedures showed a striking and statistically significant link between operator commitment to the transradial approach and the ability to give patients a mortality benefit by using the transradial approach. This analysis subdivided the patients into three categories depending on the frequency at which the center where they were treated performed transradial PCI. The three subgroups were centers that did 64% or fewer of their cases transradially, centers that did 65%-79% of their patients transradially, and centers that did 80% or more of their cases via the radial artery.

The data showed that patients treated at centers that used the transradial approach in no more than 64% of their cases actually had a small trend toward better 30-day survival rates when they underwent a transfemoral procedure, although it was not a statistically significant difference. Among the subgroup of patients treated at centers that fell into the middle range of transradial use in everyday practice there was a trend toward better survival with transradial treatment, compared with transfemoral, but again not a statistically significant difference.

It was only among the patients treated at centers that used transradial access nearly all the time, for 80% or more of cases, where transradial use made a statistically significant difference in survival. In this subgroup, patients treated transradially had a 52% relative survival advantage compared with similar patients treated at the same center but via a transfemoral approach.

In other words, when a center in the MATRIX trial did at least 80% of cases with the transradial approach, the patients treated there that way had less than half the 30-day mortality rate, compared with similar patients treated at the same center but by PCI that used a transfemoral approach.

Choosing the PCI access site has moved beyond physician preference and convenience. It’s a matter of patient well-being.

 

 

[email protected]

On Twitter @mitchelzoler

References

Meeting/Event
Author and Disclosure Information

Publications
Topics
Legacy Keywords
PCI, radial artery, femoral artery, transradial, transfemoral, MATRIX, acute coronary syndrome, Mehran
Sections
Author and Disclosure Information

Author and Disclosure Information

Meeting/Event
Meeting/Event
Related Articles

Why are American cardiologists so far behind the worldwide curve in performing percutaneous coronary interventions by the radial-artery route?

The degree to which ACS patients suffer needlessly when they undergo percutaneous coronary intervention (PCI) via their femoral artery and not with transradial access was finally, definitively demonstrated in results from the MATRIX Access trial, presented earlier this week at the annual meeting of the American College of Cardiology. The MATRIX results showed in more than 8,000 patients that using a transradial approach for PCI was linked with a statistically significant improvement in 30-day patient survival, a 0.6% absolute difference. For every 167 patients treated by the transradial route, an additional patient lived, compared with similar patients treated with transfemoral access.

Dr. Roxana Mehran

The radial approach also cut serious access-site bleeding episodes by an absolute 0.7%, and it was this difference that appeared to mainly drive the difference in patient survival. As study discussant Dr. Roxana Mehran declared from the dais following the MATRIX report, “Bleeding matters! Here is where it’s been proven.”

Results from a second, unrelated trial reported at the meeting, TOTAL, showed that during 2010-2014, in more than 10,000 patients with ST-elevation myocardial infarction treated by PCI in 20 different countries, 68% of patients underwent their procedure via a transradial route.

In contrast, cardiologists I spoke with at the meeting said that recent estimates of PCI use by U.S. interventionalists indicated that they perform roughly 20% of PCIs transradially. That level substantially jumped over the past decade; 10 years ago U.S. transradial use stood at about 3% of all PCIs, my sources said. But 20% still lags woefully behind a worldwide rate of 68%, especially when access site can make a life-or-death difference.

Interventionalists at the meeting also told me some reasons why transfemoral access remains favored. First, it’s the approach many operators first trained in, so they are more familiar and comfortable with it. Second, transradial PCI can take longer, result in higher radiation exposure, and in some patients it’s simply impossible, which means crossover to transfemoral anyway. Finally, transfemoral PCI is just plain easier, they said.

Courtesy Wikipedia Commons/Henry Gray/Public Domain

Most of these reasons fall flat when contrasted with causing significantly fewer serious bleeds and improved survival. Of course, when transradial proves impossible there is no choice other than going with transfemoral, but as proponents of transradial said at the meeting, it is a matter of making transradial the initial, default strategy and only resorting to transfemoral when absolutely necessary.

The MATRIX results had another very important finding: To get the best outcomes, centers that offer PCI to acute coronary syndrome patients can’t simply dabble with the transradial approach; they need to be all in. A subanalysis of the MATRIX mortality benefit for transradial procedures showed a striking and statistically significant link between operator commitment to the transradial approach and the ability to give patients a mortality benefit by using the transradial approach. This analysis subdivided the patients into three categories depending on the frequency at which the center where they were treated performed transradial PCI. The three subgroups were centers that did 64% or fewer of their cases transradially, centers that did 65%-79% of their patients transradially, and centers that did 80% or more of their cases via the radial artery.

The data showed that patients treated at centers that used the transradial approach in no more than 64% of their cases actually had a small trend toward better 30-day survival rates when they underwent a transfemoral procedure, although it was not a statistically significant difference. Among the subgroup of patients treated at centers that fell into the middle range of transradial use in everyday practice there was a trend toward better survival with transradial treatment, compared with transfemoral, but again not a statistically significant difference.

It was only among the patients treated at centers that used transradial access nearly all the time, for 80% or more of cases, where transradial use made a statistically significant difference in survival. In this subgroup, patients treated transradially had a 52% relative survival advantage compared with similar patients treated at the same center but via a transfemoral approach.

In other words, when a center in the MATRIX trial did at least 80% of cases with the transradial approach, the patients treated there that way had less than half the 30-day mortality rate, compared with similar patients treated at the same center but by PCI that used a transfemoral approach.

Choosing the PCI access site has moved beyond physician preference and convenience. It’s a matter of patient well-being.

 

 

[email protected]

On Twitter @mitchelzoler

Why are American cardiologists so far behind the worldwide curve in performing percutaneous coronary interventions by the radial-artery route?

The degree to which ACS patients suffer needlessly when they undergo percutaneous coronary intervention (PCI) via their femoral artery and not with transradial access was finally, definitively demonstrated in results from the MATRIX Access trial, presented earlier this week at the annual meeting of the American College of Cardiology. The MATRIX results showed in more than 8,000 patients that using a transradial approach for PCI was linked with a statistically significant improvement in 30-day patient survival, a 0.6% absolute difference. For every 167 patients treated by the transradial route, an additional patient lived, compared with similar patients treated with transfemoral access.

Dr. Roxana Mehran

The radial approach also cut serious access-site bleeding episodes by an absolute 0.7%, and it was this difference that appeared to mainly drive the difference in patient survival. As study discussant Dr. Roxana Mehran declared from the dais following the MATRIX report, “Bleeding matters! Here is where it’s been proven.”

Results from a second, unrelated trial reported at the meeting, TOTAL, showed that during 2010-2014, in more than 10,000 patients with ST-elevation myocardial infarction treated by PCI in 20 different countries, 68% of patients underwent their procedure via a transradial route.

In contrast, cardiologists I spoke with at the meeting said that recent estimates of PCI use by U.S. interventionalists indicated that they perform roughly 20% of PCIs transradially. That level substantially jumped over the past decade; 10 years ago U.S. transradial use stood at about 3% of all PCIs, my sources said. But 20% still lags woefully behind a worldwide rate of 68%, especially when access site can make a life-or-death difference.

Interventionalists at the meeting also told me some reasons why transfemoral access remains favored. First, it’s the approach many operators first trained in, so they are more familiar and comfortable with it. Second, transradial PCI can take longer, result in higher radiation exposure, and in some patients it’s simply impossible, which means crossover to transfemoral anyway. Finally, transfemoral PCI is just plain easier, they said.

Courtesy Wikipedia Commons/Henry Gray/Public Domain

Most of these reasons fall flat when contrasted with causing significantly fewer serious bleeds and improved survival. Of course, when transradial proves impossible there is no choice other than going with transfemoral, but as proponents of transradial said at the meeting, it is a matter of making transradial the initial, default strategy and only resorting to transfemoral when absolutely necessary.

The MATRIX results had another very important finding: To get the best outcomes, centers that offer PCI to acute coronary syndrome patients can’t simply dabble with the transradial approach; they need to be all in. A subanalysis of the MATRIX mortality benefit for transradial procedures showed a striking and statistically significant link between operator commitment to the transradial approach and the ability to give patients a mortality benefit by using the transradial approach. This analysis subdivided the patients into three categories depending on the frequency at which the center where they were treated performed transradial PCI. The three subgroups were centers that did 64% or fewer of their cases transradially, centers that did 65%-79% of their patients transradially, and centers that did 80% or more of their cases via the radial artery.

The data showed that patients treated at centers that used the transradial approach in no more than 64% of their cases actually had a small trend toward better 30-day survival rates when they underwent a transfemoral procedure, although it was not a statistically significant difference. Among the subgroup of patients treated at centers that fell into the middle range of transradial use in everyday practice there was a trend toward better survival with transradial treatment, compared with transfemoral, but again not a statistically significant difference.

It was only among the patients treated at centers that used transradial access nearly all the time, for 80% or more of cases, where transradial use made a statistically significant difference in survival. In this subgroup, patients treated transradially had a 52% relative survival advantage compared with similar patients treated at the same center but via a transfemoral approach.

In other words, when a center in the MATRIX trial did at least 80% of cases with the transradial approach, the patients treated there that way had less than half the 30-day mortality rate, compared with similar patients treated at the same center but by PCI that used a transfemoral approach.

Choosing the PCI access site has moved beyond physician preference and convenience. It’s a matter of patient well-being.

 

 

[email protected]

On Twitter @mitchelzoler

References

References

Publications
Publications
Topics
Article Type
Display Headline
U.S. lagging on transradial PCI endangers patients
Display Headline
U.S. lagging on transradial PCI endangers patients
Legacy Keywords
PCI, radial artery, femoral artery, transradial, transfemoral, MATRIX, acute coronary syndrome, Mehran
Legacy Keywords
PCI, radial artery, femoral artery, transradial, transfemoral, MATRIX, acute coronary syndrome, Mehran
Sections
Article Source

PURLs Copyright

Inside the Article

Time to listen

Article Type
Changed
Thu, 03/28/2019 - 15:29
Display Headline
Time to listen

Doctors talk more than they listen, especially when discussing end-of-life care with families, a recent study in Pediatrics suggests. Researchers from the University of Amsterdam followed 27 physicians and 37 parents as they navigated the difficult waters of end-of-life decision making for their children. By analyzing recorded conversations, they found that physicians spoke 67% of the time, while parents spoke only 30% of the time and nurses 3%. Additionally, they found that physicians “focused primarily on providing medical information, explaining the preferred course of action, and informing parents about the decision being reached by the team”(Pediatrics 2015;135:e465-76). Although parents were present during discussions, they were not routinely part of the decision-making process.

While this study was performed in Amsterdam and may not perfectly reflect the cultural norms of the United States, the results still should give us pause and raise important questions. Do we spend too much time talking, and too little listening? What role do parents have in decision making in our own country? Although we all participate in family-centered rounds, how often are the parents present but not involved? Do we pause often enough to explain in plain English what we had just rattled off in medicalese?

Dr. Bryan Sisk

The challenge of listening is that it takes time and energy. With many other patients to care for and a long list of notes and orders to be entered, spending more time listening to families can seem exhausting and less important. However, this is the crux of the physician-patient relationship, and this is what makes the role of physician so important. When sick children and their families are at the most vulnerable point in their lives, it is our presence as empathizing, listening humans that matters most. Treating the disease with the correct medications is important but insufficient. And the sicker the patient, the higher the stakes.

As medical trainees, we often can feel powerless in these high-intensity situations. Yet, we can play a key role by advocating on behalf of our patients and their families, by giving them a voice. We can do this only by taking time to ask questions and to listen. After spending a few more minutes with these families in need, we can better understand their hopes and values, and we can identify the ways in which our goals align. As our medical teams are zipping through family-centered-rounds, we can advocate for families by raising their questions and concerns, ensuring that their voices are heard. By taking time to listen, we can provide that pivotal bridge of understanding between the medical team and the family.

Dr. Sisk is a pediatrics resident at St. Louis Children’s Hospital. E-mail him at [email protected].

References

Author and Disclosure Information

Publications
Topics
Legacy Keywords
listen, end of life decisions, family-centered rounds
Sections
Author and Disclosure Information

Author and Disclosure Information

Doctors talk more than they listen, especially when discussing end-of-life care with families, a recent study in Pediatrics suggests. Researchers from the University of Amsterdam followed 27 physicians and 37 parents as they navigated the difficult waters of end-of-life decision making for their children. By analyzing recorded conversations, they found that physicians spoke 67% of the time, while parents spoke only 30% of the time and nurses 3%. Additionally, they found that physicians “focused primarily on providing medical information, explaining the preferred course of action, and informing parents about the decision being reached by the team”(Pediatrics 2015;135:e465-76). Although parents were present during discussions, they were not routinely part of the decision-making process.

While this study was performed in Amsterdam and may not perfectly reflect the cultural norms of the United States, the results still should give us pause and raise important questions. Do we spend too much time talking, and too little listening? What role do parents have in decision making in our own country? Although we all participate in family-centered rounds, how often are the parents present but not involved? Do we pause often enough to explain in plain English what we had just rattled off in medicalese?

Dr. Bryan Sisk

The challenge of listening is that it takes time and energy. With many other patients to care for and a long list of notes and orders to be entered, spending more time listening to families can seem exhausting and less important. However, this is the crux of the physician-patient relationship, and this is what makes the role of physician so important. When sick children and their families are at the most vulnerable point in their lives, it is our presence as empathizing, listening humans that matters most. Treating the disease with the correct medications is important but insufficient. And the sicker the patient, the higher the stakes.

As medical trainees, we often can feel powerless in these high-intensity situations. Yet, we can play a key role by advocating on behalf of our patients and their families, by giving them a voice. We can do this only by taking time to ask questions and to listen. After spending a few more minutes with these families in need, we can better understand their hopes and values, and we can identify the ways in which our goals align. As our medical teams are zipping through family-centered-rounds, we can advocate for families by raising their questions and concerns, ensuring that their voices are heard. By taking time to listen, we can provide that pivotal bridge of understanding between the medical team and the family.

Dr. Sisk is a pediatrics resident at St. Louis Children’s Hospital. E-mail him at [email protected].

Doctors talk more than they listen, especially when discussing end-of-life care with families, a recent study in Pediatrics suggests. Researchers from the University of Amsterdam followed 27 physicians and 37 parents as they navigated the difficult waters of end-of-life decision making for their children. By analyzing recorded conversations, they found that physicians spoke 67% of the time, while parents spoke only 30% of the time and nurses 3%. Additionally, they found that physicians “focused primarily on providing medical information, explaining the preferred course of action, and informing parents about the decision being reached by the team”(Pediatrics 2015;135:e465-76). Although parents were present during discussions, they were not routinely part of the decision-making process.

While this study was performed in Amsterdam and may not perfectly reflect the cultural norms of the United States, the results still should give us pause and raise important questions. Do we spend too much time talking, and too little listening? What role do parents have in decision making in our own country? Although we all participate in family-centered rounds, how often are the parents present but not involved? Do we pause often enough to explain in plain English what we had just rattled off in medicalese?

Dr. Bryan Sisk

The challenge of listening is that it takes time and energy. With many other patients to care for and a long list of notes and orders to be entered, spending more time listening to families can seem exhausting and less important. However, this is the crux of the physician-patient relationship, and this is what makes the role of physician so important. When sick children and their families are at the most vulnerable point in their lives, it is our presence as empathizing, listening humans that matters most. Treating the disease with the correct medications is important but insufficient. And the sicker the patient, the higher the stakes.

As medical trainees, we often can feel powerless in these high-intensity situations. Yet, we can play a key role by advocating on behalf of our patients and their families, by giving them a voice. We can do this only by taking time to ask questions and to listen. After spending a few more minutes with these families in need, we can better understand their hopes and values, and we can identify the ways in which our goals align. As our medical teams are zipping through family-centered-rounds, we can advocate for families by raising their questions and concerns, ensuring that their voices are heard. By taking time to listen, we can provide that pivotal bridge of understanding between the medical team and the family.

Dr. Sisk is a pediatrics resident at St. Louis Children’s Hospital. E-mail him at [email protected].

References

References

Publications
Publications
Topics
Article Type
Display Headline
Time to listen
Display Headline
Time to listen
Legacy Keywords
listen, end of life decisions, family-centered rounds
Legacy Keywords
listen, end of life decisions, family-centered rounds
Sections
Article Source

PURLs Copyright

Inside the Article

Can we do less?

Article Type
Changed
Fri, 01/18/2019 - 14:34
Display Headline
Can we do less?

It is a busy night in the emergency department, and patients are lining up in the waiting room. The next patient is a 2-year-old boy with a cough, runny nose, and increased work of breathing. My stethoscope picks up a chorus of noises in his lungs, but no wheezes. The attending physician walks into the room with me, a pediatrics resident, and the mother looks on expectantly, hoping I will make her baby better.

The attending agrees with me, this child is doing poorly and needs to be admitted. Then the question comes: “What do you want to do for him?” A few minutes later, the patient is receiving an albuterol treatment. Unsurprisingly, he does not improve, but soon he disappears off to the floor and I move onto the next patient.

In medicine, the urge to help patients drives physicians every day. The true challenge comes when the only way to help patients is by doing less. In 2014, the American Academy of Pediatrics released new bronchiolitis treatment guidelines. In this document, they cited numerous studies showing lack of benefit from albuterol or racemic epinephrine treatments, and they recommended against treatment trials in children with bronchiolitis. Additionally, they recommended against X-rays and steroids. This leaves pediatricians with the unsatisfying options of suctioning, watching, and waiting.

Physicians tend to be “fixers” by nature. Patients come to us to feel better, and we feel driven (internally and externally) to provide these cures. This desire can drive us to prescribe antibiotics for presumed viral infections, order imaging for minor head injuries, or offer trial bronchodilators in the setting of bronchiolitis. As medical trainees, we have the additional onus of answering to our attending physicians. Perhaps we are willing to watch a patient with bronchiolitis slowly evolve, but maybe some of our supervisors are not. How firmly do we stand our ground? What authority do we have?

Perhaps we have more to offer than we think. As trainees, we are exposed to education and updates from diverse fields of pediatrics, and this developing knowledge base can benefit our medical teams. We can utilize our knowledge of neurology to abort a seizure on the oncology floor. We can guide the evaluation for anemia while at an outpatient clinic. And we can apply our awareness of bronchiolitis guidelines to patients in the ED. By continuing to develop and apply an evidence base for our medical practice, we can provide meaningful insights about which interventions should (or should not) be done for our patients. Although uncomfortable at times, such situations provide us with the opportunity to improve medical practice while protecting our patients from unintended harms, gently remind our attending physicians which interventions should (or should not) be done for our patients. With education and a bit of spine, we can help our medical teams to follow that foremost of imperatives for the medical profession: Primum non nocere – First do no harm.

Dr. Sisk is a pediatrics resident at St. Louis Children’s Hospital. E-mail him at [email protected].

References

Author and Disclosure Information

Publications
Legacy Keywords
emergency department, attending physician, resident
Sections
Author and Disclosure Information

Author and Disclosure Information

It is a busy night in the emergency department, and patients are lining up in the waiting room. The next patient is a 2-year-old boy with a cough, runny nose, and increased work of breathing. My stethoscope picks up a chorus of noises in his lungs, but no wheezes. The attending physician walks into the room with me, a pediatrics resident, and the mother looks on expectantly, hoping I will make her baby better.

The attending agrees with me, this child is doing poorly and needs to be admitted. Then the question comes: “What do you want to do for him?” A few minutes later, the patient is receiving an albuterol treatment. Unsurprisingly, he does not improve, but soon he disappears off to the floor and I move onto the next patient.

In medicine, the urge to help patients drives physicians every day. The true challenge comes when the only way to help patients is by doing less. In 2014, the American Academy of Pediatrics released new bronchiolitis treatment guidelines. In this document, they cited numerous studies showing lack of benefit from albuterol or racemic epinephrine treatments, and they recommended against treatment trials in children with bronchiolitis. Additionally, they recommended against X-rays and steroids. This leaves pediatricians with the unsatisfying options of suctioning, watching, and waiting.

Physicians tend to be “fixers” by nature. Patients come to us to feel better, and we feel driven (internally and externally) to provide these cures. This desire can drive us to prescribe antibiotics for presumed viral infections, order imaging for minor head injuries, or offer trial bronchodilators in the setting of bronchiolitis. As medical trainees, we have the additional onus of answering to our attending physicians. Perhaps we are willing to watch a patient with bronchiolitis slowly evolve, but maybe some of our supervisors are not. How firmly do we stand our ground? What authority do we have?

Perhaps we have more to offer than we think. As trainees, we are exposed to education and updates from diverse fields of pediatrics, and this developing knowledge base can benefit our medical teams. We can utilize our knowledge of neurology to abort a seizure on the oncology floor. We can guide the evaluation for anemia while at an outpatient clinic. And we can apply our awareness of bronchiolitis guidelines to patients in the ED. By continuing to develop and apply an evidence base for our medical practice, we can provide meaningful insights about which interventions should (or should not) be done for our patients. Although uncomfortable at times, such situations provide us with the opportunity to improve medical practice while protecting our patients from unintended harms, gently remind our attending physicians which interventions should (or should not) be done for our patients. With education and a bit of spine, we can help our medical teams to follow that foremost of imperatives for the medical profession: Primum non nocere – First do no harm.

Dr. Sisk is a pediatrics resident at St. Louis Children’s Hospital. E-mail him at [email protected].

It is a busy night in the emergency department, and patients are lining up in the waiting room. The next patient is a 2-year-old boy with a cough, runny nose, and increased work of breathing. My stethoscope picks up a chorus of noises in his lungs, but no wheezes. The attending physician walks into the room with me, a pediatrics resident, and the mother looks on expectantly, hoping I will make her baby better.

The attending agrees with me, this child is doing poorly and needs to be admitted. Then the question comes: “What do you want to do for him?” A few minutes later, the patient is receiving an albuterol treatment. Unsurprisingly, he does not improve, but soon he disappears off to the floor and I move onto the next patient.

In medicine, the urge to help patients drives physicians every day. The true challenge comes when the only way to help patients is by doing less. In 2014, the American Academy of Pediatrics released new bronchiolitis treatment guidelines. In this document, they cited numerous studies showing lack of benefit from albuterol or racemic epinephrine treatments, and they recommended against treatment trials in children with bronchiolitis. Additionally, they recommended against X-rays and steroids. This leaves pediatricians with the unsatisfying options of suctioning, watching, and waiting.

Physicians tend to be “fixers” by nature. Patients come to us to feel better, and we feel driven (internally and externally) to provide these cures. This desire can drive us to prescribe antibiotics for presumed viral infections, order imaging for minor head injuries, or offer trial bronchodilators in the setting of bronchiolitis. As medical trainees, we have the additional onus of answering to our attending physicians. Perhaps we are willing to watch a patient with bronchiolitis slowly evolve, but maybe some of our supervisors are not. How firmly do we stand our ground? What authority do we have?

Perhaps we have more to offer than we think. As trainees, we are exposed to education and updates from diverse fields of pediatrics, and this developing knowledge base can benefit our medical teams. We can utilize our knowledge of neurology to abort a seizure on the oncology floor. We can guide the evaluation for anemia while at an outpatient clinic. And we can apply our awareness of bronchiolitis guidelines to patients in the ED. By continuing to develop and apply an evidence base for our medical practice, we can provide meaningful insights about which interventions should (or should not) be done for our patients. Although uncomfortable at times, such situations provide us with the opportunity to improve medical practice while protecting our patients from unintended harms, gently remind our attending physicians which interventions should (or should not) be done for our patients. With education and a bit of spine, we can help our medical teams to follow that foremost of imperatives for the medical profession: Primum non nocere – First do no harm.

Dr. Sisk is a pediatrics resident at St. Louis Children’s Hospital. E-mail him at [email protected].

References

References

Publications
Publications
Article Type
Display Headline
Can we do less?
Display Headline
Can we do less?
Legacy Keywords
emergency department, attending physician, resident
Legacy Keywords
emergency department, attending physician, resident
Sections
Article Source

PURLs Copyright

Inside the Article

Keeping your religious belief outside the office

Article Type
Changed
Fri, 01/18/2019 - 14:34
Display Headline
Keeping your religious belief outside the office

Religion isn’t an uncommon topic in a doctor’s office, and mine is no exception. Patients often express their personal beliefs in difficult situations, and part of my job is to listen and support.

But when they ask me about my own, I don’t answer. I simply tell them that I don’t discuss such things with patients.

People can have pretty strong feelings about religion, and whether I agree or disagree with them doesn’t have a place in my office. Religion, like politics, opens a can of personal opinion worms that disrupts the doctor-patient relationship. It can make things unworkable.

The last thing I want, or need, during an appointment is a debate over evolution, the perennial Middle East crisis, or belief (or lack thereof) in a deity. There are plenty of good forums to argue such subjects, but my office isn’t one of them.

On rare occasions, someone calling for an appointment will ask about my religious orientation. My secretary has been told to say “I don’t know.” If that matters to you when you’re looking for a doctor, you’re probably better off going elsewhere.

I have nothing against social pleasantries. They’re part of the ordinary patter in my office, and help maintain a degree of doctor-patient comfort to let us talk openly. But religious beliefs are a topic that, with some people, can rapidly spiral out of control. On the rare occasions where they become acrimonious, it pretty much destroys the fabric of the professional relationship. So, my belief is that it’s best not to start in the first place.

Some find religion to be an important part of who they are, and I’m willing to listen to that and not be judgmental. But don’t expect me to share my own thoughts at an appointment. It’s not why either of us is there.

Dr. Block has a solo neurology practice in Scottsdale, Ariz.

References

Author and Disclosure Information

Publications
Legacy Keywords
Hitting a Nerve, neurology
Sections
Author and Disclosure Information

Author and Disclosure Information

Religion isn’t an uncommon topic in a doctor’s office, and mine is no exception. Patients often express their personal beliefs in difficult situations, and part of my job is to listen and support.

But when they ask me about my own, I don’t answer. I simply tell them that I don’t discuss such things with patients.

People can have pretty strong feelings about religion, and whether I agree or disagree with them doesn’t have a place in my office. Religion, like politics, opens a can of personal opinion worms that disrupts the doctor-patient relationship. It can make things unworkable.

The last thing I want, or need, during an appointment is a debate over evolution, the perennial Middle East crisis, or belief (or lack thereof) in a deity. There are plenty of good forums to argue such subjects, but my office isn’t one of them.

On rare occasions, someone calling for an appointment will ask about my religious orientation. My secretary has been told to say “I don’t know.” If that matters to you when you’re looking for a doctor, you’re probably better off going elsewhere.

I have nothing against social pleasantries. They’re part of the ordinary patter in my office, and help maintain a degree of doctor-patient comfort to let us talk openly. But religious beliefs are a topic that, with some people, can rapidly spiral out of control. On the rare occasions where they become acrimonious, it pretty much destroys the fabric of the professional relationship. So, my belief is that it’s best not to start in the first place.

Some find religion to be an important part of who they are, and I’m willing to listen to that and not be judgmental. But don’t expect me to share my own thoughts at an appointment. It’s not why either of us is there.

Dr. Block has a solo neurology practice in Scottsdale, Ariz.

Religion isn’t an uncommon topic in a doctor’s office, and mine is no exception. Patients often express their personal beliefs in difficult situations, and part of my job is to listen and support.

But when they ask me about my own, I don’t answer. I simply tell them that I don’t discuss such things with patients.

People can have pretty strong feelings about religion, and whether I agree or disagree with them doesn’t have a place in my office. Religion, like politics, opens a can of personal opinion worms that disrupts the doctor-patient relationship. It can make things unworkable.

The last thing I want, or need, during an appointment is a debate over evolution, the perennial Middle East crisis, or belief (or lack thereof) in a deity. There are plenty of good forums to argue such subjects, but my office isn’t one of them.

On rare occasions, someone calling for an appointment will ask about my religious orientation. My secretary has been told to say “I don’t know.” If that matters to you when you’re looking for a doctor, you’re probably better off going elsewhere.

I have nothing against social pleasantries. They’re part of the ordinary patter in my office, and help maintain a degree of doctor-patient comfort to let us talk openly. But religious beliefs are a topic that, with some people, can rapidly spiral out of control. On the rare occasions where they become acrimonious, it pretty much destroys the fabric of the professional relationship. So, my belief is that it’s best not to start in the first place.

Some find religion to be an important part of who they are, and I’m willing to listen to that and not be judgmental. But don’t expect me to share my own thoughts at an appointment. It’s not why either of us is there.

Dr. Block has a solo neurology practice in Scottsdale, Ariz.

References

References

Publications
Publications
Article Type
Display Headline
Keeping your religious belief outside the office
Display Headline
Keeping your religious belief outside the office
Legacy Keywords
Hitting a Nerve, neurology
Legacy Keywords
Hitting a Nerve, neurology
Sections
Article Source

PURLs Copyright

Inside the Article

Apple’s ResearchKit

Article Type
Changed
Thu, 12/15/2022 - 18:05
Display Headline
Apple’s ResearchKit

Doctors have been conjecturing about how the new Apple Watch, with its spectacular fitness and wellness tracking features, will transform health care. The real rock star at Apple’s March 9 “Spring Forward” event, however, was the opening band, ResearchKit.

What is it?

ResearchKit is Apple’s (beautiful) solution to one of the great problems of medical research: recruiting subjects. ResearchKit allows researchers to collect data in a way that before today was impossible: with just a click from their smartphones. The open-source software platform allows developers to design studies and to recruit subjects right from the app store. Researchers can leverage high-tech smartphone sensors and can push out surveys, collecting both objective and subjective data from thousands (heck, potentially millions) of participants.

 

Dr. Jeffrey Benabio

Five apps were developed for the launch: mPower for Parkinson’s disease, from the University of Rochester, N.Y.; GlucoSuccess for diabetes, from Massachusetts General Hospital, Boston; MyHeart Counts for cardiovascular disease, from Stanford (Calif.) University and the University of Oxford, England; Asthma Health from Mount Sinai and Weill Medical College of Cornell University, New York, N.Y.; and Share the Journey for breast cancer, from the Dana-Farber Cancer Institute, Boston; the University of California, Los Angeles Fielding School of Public Health; and Penn Medicine, Philadelphia.

My take

I took a closer look at MyHeart Counts, which evaluates how patients’ activity levels influence their cardiovascular health. According to Stanford University, a mere 4 days after its release, the MyHeart Counts app had been downloaded 52,900 times in the United States and Canada and had more than 22,000 users who had consented to the study. Try getting that kind of response to your research study with a flyer with tear-off phone number posted in your hospital cafeteria.

I was impressed with its beautiful interface and ease of use. Designed to gather sensor and health data from your iPhone and personal devices, this app is designed to help researchers (and you) detect patterns or details about your heart health. To start, you download the app, give your consent, answer questions about your health and lifestyle, and begin recording your activity with your phone or wearable device. You do a walk test to determine your heart health and potential health risk.

What happens to the data you input? It is sent (with your permission) to a secure database, and your name is replaced with a random code. Your coded and encrypted data are then shared with scientists and physicians to use in medical research.

For this particular study, they ask you to participate 10-15 minutes per day for 1 week, then hope that you can contribute further for 1 week every 3 months answering surveys about your health, lifestyle, and physical activity. Apple reassures users that they can withdraw at any time.

Why? Who cares?

The value proposition for researchers is obvious: The platform provides access to many more subjects than even imaginable. The accelerometer, barometer, gyroscope, and GPS send interesting data to researchers friction free. The Parkinson’s app, for example, uses a cool algorithm and the phone’s microphone to detect symptoms by having patients say “ahhhh.” By pushing out questionnaires regularly, you can collect much more data with shorter intervals for longer periods of time.

The advantages for patients are equally compelling. In addition to sending their data to researchers, they also receive information back from the researchers, helping them monitor their cardiovascular health. In fact, just knowing they are participating in the study might be of benefit. As dermatologist Dr. Steve Feldman of Wake Forest Baptist Medical Center, Winston Salem, N.C., has shown, patients are more likely to adhere to therapies when they know they are being watched, a manifestation of the Hawthorne effect.

Shortcomings

Surely there is a catch? And there is. With potentially millions of participants sending self-reported data, there is the potential that ResearchKit studies glean big, beautiful, bad data. How, for example, could you verify that self-reported asthma patients actually have asthma? Maybe they just read about ResearchKit and wanted to be part of the fun.

For patients, privacy concerns are paramount. Apple promised that no one, not even Apple, will see your data without your permission. But with privacy breaches reported in the news weekly, what can Apple’s assurance mean? Didn’t Target and Aetna promise to keep your data safe as well?

The potential for interesting research is enormous. By the time you read this, I wouldn’t be surprised if a psoriasis study had already launched. In fact, a year from now, the problem might be a dozen or more interesting psoriasis studies all competing for the same patients. Ah, maybe we should be glad if we should be so lucky.

 

 

Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and volunteer clinical assistant professor at the University of California, San Diego. Dr. Benabio is @dermdoc on Twitter.

Publications
Topics
Legacy Keywords
iPhone, smartphone, Apple, ResearchKit, diabetes, Parkinson's, asthma, breast cancer, cardiovascular disease, heart
Sections

Doctors have been conjecturing about how the new Apple Watch, with its spectacular fitness and wellness tracking features, will transform health care. The real rock star at Apple’s March 9 “Spring Forward” event, however, was the opening band, ResearchKit.

What is it?

ResearchKit is Apple’s (beautiful) solution to one of the great problems of medical research: recruiting subjects. ResearchKit allows researchers to collect data in a way that before today was impossible: with just a click from their smartphones. The open-source software platform allows developers to design studies and to recruit subjects right from the app store. Researchers can leverage high-tech smartphone sensors and can push out surveys, collecting both objective and subjective data from thousands (heck, potentially millions) of participants.

 

Dr. Jeffrey Benabio

Five apps were developed for the launch: mPower for Parkinson’s disease, from the University of Rochester, N.Y.; GlucoSuccess for diabetes, from Massachusetts General Hospital, Boston; MyHeart Counts for cardiovascular disease, from Stanford (Calif.) University and the University of Oxford, England; Asthma Health from Mount Sinai and Weill Medical College of Cornell University, New York, N.Y.; and Share the Journey for breast cancer, from the Dana-Farber Cancer Institute, Boston; the University of California, Los Angeles Fielding School of Public Health; and Penn Medicine, Philadelphia.

My take

I took a closer look at MyHeart Counts, which evaluates how patients’ activity levels influence their cardiovascular health. According to Stanford University, a mere 4 days after its release, the MyHeart Counts app had been downloaded 52,900 times in the United States and Canada and had more than 22,000 users who had consented to the study. Try getting that kind of response to your research study with a flyer with tear-off phone number posted in your hospital cafeteria.

I was impressed with its beautiful interface and ease of use. Designed to gather sensor and health data from your iPhone and personal devices, this app is designed to help researchers (and you) detect patterns or details about your heart health. To start, you download the app, give your consent, answer questions about your health and lifestyle, and begin recording your activity with your phone or wearable device. You do a walk test to determine your heart health and potential health risk.

What happens to the data you input? It is sent (with your permission) to a secure database, and your name is replaced with a random code. Your coded and encrypted data are then shared with scientists and physicians to use in medical research.

For this particular study, they ask you to participate 10-15 minutes per day for 1 week, then hope that you can contribute further for 1 week every 3 months answering surveys about your health, lifestyle, and physical activity. Apple reassures users that they can withdraw at any time.

Why? Who cares?

The value proposition for researchers is obvious: The platform provides access to many more subjects than even imaginable. The accelerometer, barometer, gyroscope, and GPS send interesting data to researchers friction free. The Parkinson’s app, for example, uses a cool algorithm and the phone’s microphone to detect symptoms by having patients say “ahhhh.” By pushing out questionnaires regularly, you can collect much more data with shorter intervals for longer periods of time.

The advantages for patients are equally compelling. In addition to sending their data to researchers, they also receive information back from the researchers, helping them monitor their cardiovascular health. In fact, just knowing they are participating in the study might be of benefit. As dermatologist Dr. Steve Feldman of Wake Forest Baptist Medical Center, Winston Salem, N.C., has shown, patients are more likely to adhere to therapies when they know they are being watched, a manifestation of the Hawthorne effect.

Shortcomings

Surely there is a catch? And there is. With potentially millions of participants sending self-reported data, there is the potential that ResearchKit studies glean big, beautiful, bad data. How, for example, could you verify that self-reported asthma patients actually have asthma? Maybe they just read about ResearchKit and wanted to be part of the fun.

For patients, privacy concerns are paramount. Apple promised that no one, not even Apple, will see your data without your permission. But with privacy breaches reported in the news weekly, what can Apple’s assurance mean? Didn’t Target and Aetna promise to keep your data safe as well?

The potential for interesting research is enormous. By the time you read this, I wouldn’t be surprised if a psoriasis study had already launched. In fact, a year from now, the problem might be a dozen or more interesting psoriasis studies all competing for the same patients. Ah, maybe we should be glad if we should be so lucky.

 

 

Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and volunteer clinical assistant professor at the University of California, San Diego. Dr. Benabio is @dermdoc on Twitter.

Doctors have been conjecturing about how the new Apple Watch, with its spectacular fitness and wellness tracking features, will transform health care. The real rock star at Apple’s March 9 “Spring Forward” event, however, was the opening band, ResearchKit.

What is it?

ResearchKit is Apple’s (beautiful) solution to one of the great problems of medical research: recruiting subjects. ResearchKit allows researchers to collect data in a way that before today was impossible: with just a click from their smartphones. The open-source software platform allows developers to design studies and to recruit subjects right from the app store. Researchers can leverage high-tech smartphone sensors and can push out surveys, collecting both objective and subjective data from thousands (heck, potentially millions) of participants.

 

Dr. Jeffrey Benabio

Five apps were developed for the launch: mPower for Parkinson’s disease, from the University of Rochester, N.Y.; GlucoSuccess for diabetes, from Massachusetts General Hospital, Boston; MyHeart Counts for cardiovascular disease, from Stanford (Calif.) University and the University of Oxford, England; Asthma Health from Mount Sinai and Weill Medical College of Cornell University, New York, N.Y.; and Share the Journey for breast cancer, from the Dana-Farber Cancer Institute, Boston; the University of California, Los Angeles Fielding School of Public Health; and Penn Medicine, Philadelphia.

My take

I took a closer look at MyHeart Counts, which evaluates how patients’ activity levels influence their cardiovascular health. According to Stanford University, a mere 4 days after its release, the MyHeart Counts app had been downloaded 52,900 times in the United States and Canada and had more than 22,000 users who had consented to the study. Try getting that kind of response to your research study with a flyer with tear-off phone number posted in your hospital cafeteria.

I was impressed with its beautiful interface and ease of use. Designed to gather sensor and health data from your iPhone and personal devices, this app is designed to help researchers (and you) detect patterns or details about your heart health. To start, you download the app, give your consent, answer questions about your health and lifestyle, and begin recording your activity with your phone or wearable device. You do a walk test to determine your heart health and potential health risk.

What happens to the data you input? It is sent (with your permission) to a secure database, and your name is replaced with a random code. Your coded and encrypted data are then shared with scientists and physicians to use in medical research.

For this particular study, they ask you to participate 10-15 minutes per day for 1 week, then hope that you can contribute further for 1 week every 3 months answering surveys about your health, lifestyle, and physical activity. Apple reassures users that they can withdraw at any time.

Why? Who cares?

The value proposition for researchers is obvious: The platform provides access to many more subjects than even imaginable. The accelerometer, barometer, gyroscope, and GPS send interesting data to researchers friction free. The Parkinson’s app, for example, uses a cool algorithm and the phone’s microphone to detect symptoms by having patients say “ahhhh.” By pushing out questionnaires regularly, you can collect much more data with shorter intervals for longer periods of time.

The advantages for patients are equally compelling. In addition to sending their data to researchers, they also receive information back from the researchers, helping them monitor their cardiovascular health. In fact, just knowing they are participating in the study might be of benefit. As dermatologist Dr. Steve Feldman of Wake Forest Baptist Medical Center, Winston Salem, N.C., has shown, patients are more likely to adhere to therapies when they know they are being watched, a manifestation of the Hawthorne effect.

Shortcomings

Surely there is a catch? And there is. With potentially millions of participants sending self-reported data, there is the potential that ResearchKit studies glean big, beautiful, bad data. How, for example, could you verify that self-reported asthma patients actually have asthma? Maybe they just read about ResearchKit and wanted to be part of the fun.

For patients, privacy concerns are paramount. Apple promised that no one, not even Apple, will see your data without your permission. But with privacy breaches reported in the news weekly, what can Apple’s assurance mean? Didn’t Target and Aetna promise to keep your data safe as well?

The potential for interesting research is enormous. By the time you read this, I wouldn’t be surprised if a psoriasis study had already launched. In fact, a year from now, the problem might be a dozen or more interesting psoriasis studies all competing for the same patients. Ah, maybe we should be glad if we should be so lucky.

 

 

Dr. Benabio is a partner physician in the department of dermatology of the Southern California Permanente Group in San Diego, and volunteer clinical assistant professor at the University of California, San Diego. Dr. Benabio is @dermdoc on Twitter.

Publications
Publications
Topics
Article Type
Display Headline
Apple’s ResearchKit
Display Headline
Apple’s ResearchKit
Legacy Keywords
iPhone, smartphone, Apple, ResearchKit, diabetes, Parkinson's, asthma, breast cancer, cardiovascular disease, heart
Legacy Keywords
iPhone, smartphone, Apple, ResearchKit, diabetes, Parkinson's, asthma, breast cancer, cardiovascular disease, heart
Sections
Disallow All Ads

Addressing pain at the end of life

Article Type
Changed
Wed, 01/02/2019 - 09:09
Display Headline
Addressing pain at the end of life

A few months ago, a colleague asked me about treating a patient’s pain that he was managing for months both in and out of the hospital for what was now an incurable condition. This very skilled surgeon believed that the patient should “not require” such high doses of opioids based on the clinical picture of a healed surgical wound but felt at a loss of what else to do. He did not want to abandon his relationship with the patient. He considered referral to the anesthesia pain clinic as escalating pain requirements were exceeding his comfort level.

Dr. David Zonies

Alternatively, he considered deferring pain management to the patient’s primary care provider. Instead, we worked together through a rational pain approach and explored external factors that may have been contributing to the patient’s total pain experience. This brief vignette is not atypical and sheds light onto the ongoing need to fill an education gap for surgeons who deal with patients at the end of life.

It has been almost 25 years since the term “pain as the fifth vital sign” was first introduced into the lexicon of clinical practice. The idea was to provide as much zeal to the topic of pain as we do to a patient’s other vital physiological measures. Yet, seriously ill patients with potential life-limiting conditions continue to experience significant pain, especially at the end of life. Among patients with nonmalignant diagnoses, more than 40% experience severe pain within days of their death. For those with malignant conditions, 15%-75% report moderate to severe pain during the final weeks of life. Whether in the ICU, hospital ward, or outpatient setting, our surgical community struggles to provide effective symptomatic pain control in many patients who have transitioned from a curative pathway to one of comfort.

Although we never intend to allow patients to suffer at the end of life, barriers to appropriate pain control persist. In some case cases, patients may feel embarrassed or ashamed to accept escalating opioid doses. In other cases, patients and families may possess misconceptions about addiction to pain medication. It is important to dispel such myths and distinguish tolerance from dependence. Among opioid-naive patients, the risk of dependence (in other words, addiction) is estimated to be 0.1%.  Among patients with a history of opioid abuse, the risk of addiction is still only 1%.

Large proportions of physicians continue to report inadequate training in pain control and are reluctant to prescribe high-enough doses of opioids to relieve pain, even at the end of life. One well-described reason has been physician fear of regulatory action and possible litigation for higher than typical opioid dosing.
This was the case for my colleague who was reluctant to escalate pain control.

This in turn leads to undertreating pain which, in fact, has been a source of successful litigation. Because undertreatment of pain may be akin to patient negligence, we should strive to become more comfortable with optimal pain treatment strategies. But pain control is not merely about intravenous opioids or pain tablets. Surgeons should at least have an appreciation for, if not a better understanding, of the modern palliative care approach to “total pain.” This construct consists of four interrelated pain domains: physical, psychological (emotional), spiritual, and social.

Although we tend to focus on physical pain, other domains are influenced by anxiety, depression, and fear. If such an approach seems a bridge too far, optimal care should involve a multidisciplinary team that touches on such areas. This may be most efficiently achieved through consultation and coordination with palliative care services when available. This patient’s surgeon soon discovered that family financial concerns were contributing to the patient’s sleepless nights and worsening somatic pain.

Somewhat outside the scope of typical postoperative care, pain relief at the end of life requires dosing and medication choices for extended periods of time. When establishing a treatment strategy, the surgeon should consider the feasibility and efficacy (half-life, duration, bioavailability, active metabolites) of each modality. In our patient, standard dosing was inadequate; for some, basal doses may increase by 25%-100% for progressive disease. To support the surgeon in learning more about this important area of care, multiple online tools and websites are available to assist with pain management choices. A short while ago, I learned from my colleague that this patient died comfortably and essentially pain free for the last months of his life.

Dr. Zonies is an associate professor of surgery in the trauma/critical care division at Oregon Health & Science University, Portland.  He is board certified in hospice and palliative medicine.

References

Author and Disclosure Information

Publications
Topics
Sections
Author and Disclosure Information

Author and Disclosure Information

A few months ago, a colleague asked me about treating a patient’s pain that he was managing for months both in and out of the hospital for what was now an incurable condition. This very skilled surgeon believed that the patient should “not require” such high doses of opioids based on the clinical picture of a healed surgical wound but felt at a loss of what else to do. He did not want to abandon his relationship with the patient. He considered referral to the anesthesia pain clinic as escalating pain requirements were exceeding his comfort level.

Dr. David Zonies

Alternatively, he considered deferring pain management to the patient’s primary care provider. Instead, we worked together through a rational pain approach and explored external factors that may have been contributing to the patient’s total pain experience. This brief vignette is not atypical and sheds light onto the ongoing need to fill an education gap for surgeons who deal with patients at the end of life.

It has been almost 25 years since the term “pain as the fifth vital sign” was first introduced into the lexicon of clinical practice. The idea was to provide as much zeal to the topic of pain as we do to a patient’s other vital physiological measures. Yet, seriously ill patients with potential life-limiting conditions continue to experience significant pain, especially at the end of life. Among patients with nonmalignant diagnoses, more than 40% experience severe pain within days of their death. For those with malignant conditions, 15%-75% report moderate to severe pain during the final weeks of life. Whether in the ICU, hospital ward, or outpatient setting, our surgical community struggles to provide effective symptomatic pain control in many patients who have transitioned from a curative pathway to one of comfort.

Although we never intend to allow patients to suffer at the end of life, barriers to appropriate pain control persist. In some case cases, patients may feel embarrassed or ashamed to accept escalating opioid doses. In other cases, patients and families may possess misconceptions about addiction to pain medication. It is important to dispel such myths and distinguish tolerance from dependence. Among opioid-naive patients, the risk of dependence (in other words, addiction) is estimated to be 0.1%.  Among patients with a history of opioid abuse, the risk of addiction is still only 1%.

Large proportions of physicians continue to report inadequate training in pain control and are reluctant to prescribe high-enough doses of opioids to relieve pain, even at the end of life. One well-described reason has been physician fear of regulatory action and possible litigation for higher than typical opioid dosing.
This was the case for my colleague who was reluctant to escalate pain control.

This in turn leads to undertreating pain which, in fact, has been a source of successful litigation. Because undertreatment of pain may be akin to patient negligence, we should strive to become more comfortable with optimal pain treatment strategies. But pain control is not merely about intravenous opioids or pain tablets. Surgeons should at least have an appreciation for, if not a better understanding, of the modern palliative care approach to “total pain.” This construct consists of four interrelated pain domains: physical, psychological (emotional), spiritual, and social.

Although we tend to focus on physical pain, other domains are influenced by anxiety, depression, and fear. If such an approach seems a bridge too far, optimal care should involve a multidisciplinary team that touches on such areas. This may be most efficiently achieved through consultation and coordination with palliative care services when available. This patient’s surgeon soon discovered that family financial concerns were contributing to the patient’s sleepless nights and worsening somatic pain.

Somewhat outside the scope of typical postoperative care, pain relief at the end of life requires dosing and medication choices for extended periods of time. When establishing a treatment strategy, the surgeon should consider the feasibility and efficacy (half-life, duration, bioavailability, active metabolites) of each modality. In our patient, standard dosing was inadequate; for some, basal doses may increase by 25%-100% for progressive disease. To support the surgeon in learning more about this important area of care, multiple online tools and websites are available to assist with pain management choices. A short while ago, I learned from my colleague that this patient died comfortably and essentially pain free for the last months of his life.

Dr. Zonies is an associate professor of surgery in the trauma/critical care division at Oregon Health & Science University, Portland.  He is board certified in hospice and palliative medicine.

A few months ago, a colleague asked me about treating a patient’s pain that he was managing for months both in and out of the hospital for what was now an incurable condition. This very skilled surgeon believed that the patient should “not require” such high doses of opioids based on the clinical picture of a healed surgical wound but felt at a loss of what else to do. He did not want to abandon his relationship with the patient. He considered referral to the anesthesia pain clinic as escalating pain requirements were exceeding his comfort level.

Dr. David Zonies

Alternatively, he considered deferring pain management to the patient’s primary care provider. Instead, we worked together through a rational pain approach and explored external factors that may have been contributing to the patient’s total pain experience. This brief vignette is not atypical and sheds light onto the ongoing need to fill an education gap for surgeons who deal with patients at the end of life.

It has been almost 25 years since the term “pain as the fifth vital sign” was first introduced into the lexicon of clinical practice. The idea was to provide as much zeal to the topic of pain as we do to a patient’s other vital physiological measures. Yet, seriously ill patients with potential life-limiting conditions continue to experience significant pain, especially at the end of life. Among patients with nonmalignant diagnoses, more than 40% experience severe pain within days of their death. For those with malignant conditions, 15%-75% report moderate to severe pain during the final weeks of life. Whether in the ICU, hospital ward, or outpatient setting, our surgical community struggles to provide effective symptomatic pain control in many patients who have transitioned from a curative pathway to one of comfort.

Although we never intend to allow patients to suffer at the end of life, barriers to appropriate pain control persist. In some case cases, patients may feel embarrassed or ashamed to accept escalating opioid doses. In other cases, patients and families may possess misconceptions about addiction to pain medication. It is important to dispel such myths and distinguish tolerance from dependence. Among opioid-naive patients, the risk of dependence (in other words, addiction) is estimated to be 0.1%.  Among patients with a history of opioid abuse, the risk of addiction is still only 1%.

Large proportions of physicians continue to report inadequate training in pain control and are reluctant to prescribe high-enough doses of opioids to relieve pain, even at the end of life. One well-described reason has been physician fear of regulatory action and possible litigation for higher than typical opioid dosing.
This was the case for my colleague who was reluctant to escalate pain control.

This in turn leads to undertreating pain which, in fact, has been a source of successful litigation. Because undertreatment of pain may be akin to patient negligence, we should strive to become more comfortable with optimal pain treatment strategies. But pain control is not merely about intravenous opioids or pain tablets. Surgeons should at least have an appreciation for, if not a better understanding, of the modern palliative care approach to “total pain.” This construct consists of four interrelated pain domains: physical, psychological (emotional), spiritual, and social.

Although we tend to focus on physical pain, other domains are influenced by anxiety, depression, and fear. If such an approach seems a bridge too far, optimal care should involve a multidisciplinary team that touches on such areas. This may be most efficiently achieved through consultation and coordination with palliative care services when available. This patient’s surgeon soon discovered that family financial concerns were contributing to the patient’s sleepless nights and worsening somatic pain.

Somewhat outside the scope of typical postoperative care, pain relief at the end of life requires dosing and medication choices for extended periods of time. When establishing a treatment strategy, the surgeon should consider the feasibility and efficacy (half-life, duration, bioavailability, active metabolites) of each modality. In our patient, standard dosing was inadequate; for some, basal doses may increase by 25%-100% for progressive disease. To support the surgeon in learning more about this important area of care, multiple online tools and websites are available to assist with pain management choices. A short while ago, I learned from my colleague that this patient died comfortably and essentially pain free for the last months of his life.

Dr. Zonies is an associate professor of surgery in the trauma/critical care division at Oregon Health & Science University, Portland.  He is board certified in hospice and palliative medicine.

References

References

Publications
Publications
Topics
Article Type
Display Headline
Addressing pain at the end of life
Display Headline
Addressing pain at the end of life
Sections
Article Source

PURLs Copyright

Inside the Article

Sharpening the saw

Article Type
Changed
Mon, 01/14/2019 - 09:12
Display Headline
Sharpening the saw

Recently, I wrote that springtime is an excellent time to spruce up your office, to check your equipment for malfunctions, to resharpen your curettes and scissors, and to back up your computer files and upgrade software. More important than any of that, though, is reevaluating your most important asset: yourself.

I write this reminder every couple of years because it’s so easy to lose sight of the big picture among the pressures of our daily routines. Sooner or later, no matter how dedicated we are, the grind gets to all of us, leading to fatigue, irritability, and a progressive decline in motivation. And we are too busy to sit down and think about what we might do to break that vicious cycle. This is detrimental to our own well-being, as well as that of our patients.

There are many ways to maintain your intellectual and emotional health, but here’s how I do it: I take individual days off (average of 1 a month) to catch up on journals or taking a CME course; or to try something new – something I’ve been thinking about doing “someday, when there is time” – such as a piano or sailing lesson; or a long weekend away with my wife. And I take no less than 4 weeks vacation per year.

I know how some of you feel about “wasting” a workday. Vacations are even worse, because patients might go elsewhere while we’re gone, and every day the office is idle we “lose money.”

That whole paradigm is wrong. Stop thinking day to day; think year to year instead. You bring in a given amount of revenue per year – more on some days, less on other days, none on weekends and vacation days; it all averages out in the end.

Besides, this is much more important than money. This is breaking the routine, clearing the cobwebs, living your life. Trust me – your practice will still be there when you return.

Last month, my wife and I hiked up a mountain in the Himalayas to the fabled Tiger’s Nest Monastery in Bhutan. As I huffed and puffed up the trail, I didn’t have the time – or the slightest inclination – to worry about the office. When the trek was over, I returned ready to take on the world, and my practice, anew.

And I jotted down some great ideas – practical, medical, and literary. Original thoughts are hard to come by during the daily grind, but they often appear, unannounced, in a new and refreshing environment.

Creative people have long recognized the value of “sharpening the saw.” A classic example is the oft-told story of Swiss physicist K. Alex Müller and German physicist J. Georg Bednorz. In 1986, they reached a major impasse in their superconductivity research; it appeared 2 decades of work might be for naught. The harder they pressed, the more elusive the answer became. So Müller decided to take some time off, put aside his troubles, and research a subject that had always interested him: ceramics.

Nothing could have been further from his research field, of course, since ceramics are among the poorest conductors known. Yet, as he relaxed, it occurred to Müller that a unique property of ceramics might apply to their project. Back in the lab, the team created a ceramic compound that became the first successful “high-temperature” superconductor.

The rest, as they say, is history; Müller and Bednorz won a Nobel Prize and triggered an explosion of research leading to breakthroughs in computing, electricity transmission, magnetically levitated trains, and many other applications that are still being realized.

Sharpening your saw may not change the world, but it will change you; any nudge out of your comfort zone will give you fresh ideas and help you look at the same old problems in completely new ways.

And to those who still can’t bear the thought of taking time off, remember Eastern’s First Law: Your last words will NOT be, “I wish I had spent more time in the office!”

Dr. Eastern practices dermatology and dermatologic surgery in Belleville, N.J. He is the author of numerous articles and textbook chapters, and is a longtime monthly columnist for Dermatology News.

References

Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

Recently, I wrote that springtime is an excellent time to spruce up your office, to check your equipment for malfunctions, to resharpen your curettes and scissors, and to back up your computer files and upgrade software. More important than any of that, though, is reevaluating your most important asset: yourself.

I write this reminder every couple of years because it’s so easy to lose sight of the big picture among the pressures of our daily routines. Sooner or later, no matter how dedicated we are, the grind gets to all of us, leading to fatigue, irritability, and a progressive decline in motivation. And we are too busy to sit down and think about what we might do to break that vicious cycle. This is detrimental to our own well-being, as well as that of our patients.

There are many ways to maintain your intellectual and emotional health, but here’s how I do it: I take individual days off (average of 1 a month) to catch up on journals or taking a CME course; or to try something new – something I’ve been thinking about doing “someday, when there is time” – such as a piano or sailing lesson; or a long weekend away with my wife. And I take no less than 4 weeks vacation per year.

I know how some of you feel about “wasting” a workday. Vacations are even worse, because patients might go elsewhere while we’re gone, and every day the office is idle we “lose money.”

That whole paradigm is wrong. Stop thinking day to day; think year to year instead. You bring in a given amount of revenue per year – more on some days, less on other days, none on weekends and vacation days; it all averages out in the end.

Besides, this is much more important than money. This is breaking the routine, clearing the cobwebs, living your life. Trust me – your practice will still be there when you return.

Last month, my wife and I hiked up a mountain in the Himalayas to the fabled Tiger’s Nest Monastery in Bhutan. As I huffed and puffed up the trail, I didn’t have the time – or the slightest inclination – to worry about the office. When the trek was over, I returned ready to take on the world, and my practice, anew.

And I jotted down some great ideas – practical, medical, and literary. Original thoughts are hard to come by during the daily grind, but they often appear, unannounced, in a new and refreshing environment.

Creative people have long recognized the value of “sharpening the saw.” A classic example is the oft-told story of Swiss physicist K. Alex Müller and German physicist J. Georg Bednorz. In 1986, they reached a major impasse in their superconductivity research; it appeared 2 decades of work might be for naught. The harder they pressed, the more elusive the answer became. So Müller decided to take some time off, put aside his troubles, and research a subject that had always interested him: ceramics.

Nothing could have been further from his research field, of course, since ceramics are among the poorest conductors known. Yet, as he relaxed, it occurred to Müller that a unique property of ceramics might apply to their project. Back in the lab, the team created a ceramic compound that became the first successful “high-temperature” superconductor.

The rest, as they say, is history; Müller and Bednorz won a Nobel Prize and triggered an explosion of research leading to breakthroughs in computing, electricity transmission, magnetically levitated trains, and many other applications that are still being realized.

Sharpening your saw may not change the world, but it will change you; any nudge out of your comfort zone will give you fresh ideas and help you look at the same old problems in completely new ways.

And to those who still can’t bear the thought of taking time off, remember Eastern’s First Law: Your last words will NOT be, “I wish I had spent more time in the office!”

Dr. Eastern practices dermatology and dermatologic surgery in Belleville, N.J. He is the author of numerous articles and textbook chapters, and is a longtime monthly columnist for Dermatology News.

Recently, I wrote that springtime is an excellent time to spruce up your office, to check your equipment for malfunctions, to resharpen your curettes and scissors, and to back up your computer files and upgrade software. More important than any of that, though, is reevaluating your most important asset: yourself.

I write this reminder every couple of years because it’s so easy to lose sight of the big picture among the pressures of our daily routines. Sooner or later, no matter how dedicated we are, the grind gets to all of us, leading to fatigue, irritability, and a progressive decline in motivation. And we are too busy to sit down and think about what we might do to break that vicious cycle. This is detrimental to our own well-being, as well as that of our patients.

There are many ways to maintain your intellectual and emotional health, but here’s how I do it: I take individual days off (average of 1 a month) to catch up on journals or taking a CME course; or to try something new – something I’ve been thinking about doing “someday, when there is time” – such as a piano or sailing lesson; or a long weekend away with my wife. And I take no less than 4 weeks vacation per year.

I know how some of you feel about “wasting” a workday. Vacations are even worse, because patients might go elsewhere while we’re gone, and every day the office is idle we “lose money.”

That whole paradigm is wrong. Stop thinking day to day; think year to year instead. You bring in a given amount of revenue per year – more on some days, less on other days, none on weekends and vacation days; it all averages out in the end.

Besides, this is much more important than money. This is breaking the routine, clearing the cobwebs, living your life. Trust me – your practice will still be there when you return.

Last month, my wife and I hiked up a mountain in the Himalayas to the fabled Tiger’s Nest Monastery in Bhutan. As I huffed and puffed up the trail, I didn’t have the time – or the slightest inclination – to worry about the office. When the trek was over, I returned ready to take on the world, and my practice, anew.

And I jotted down some great ideas – practical, medical, and literary. Original thoughts are hard to come by during the daily grind, but they often appear, unannounced, in a new and refreshing environment.

Creative people have long recognized the value of “sharpening the saw.” A classic example is the oft-told story of Swiss physicist K. Alex Müller and German physicist J. Georg Bednorz. In 1986, they reached a major impasse in their superconductivity research; it appeared 2 decades of work might be for naught. The harder they pressed, the more elusive the answer became. So Müller decided to take some time off, put aside his troubles, and research a subject that had always interested him: ceramics.

Nothing could have been further from his research field, of course, since ceramics are among the poorest conductors known. Yet, as he relaxed, it occurred to Müller that a unique property of ceramics might apply to their project. Back in the lab, the team created a ceramic compound that became the first successful “high-temperature” superconductor.

The rest, as they say, is history; Müller and Bednorz won a Nobel Prize and triggered an explosion of research leading to breakthroughs in computing, electricity transmission, magnetically levitated trains, and many other applications that are still being realized.

Sharpening your saw may not change the world, but it will change you; any nudge out of your comfort zone will give you fresh ideas and help you look at the same old problems in completely new ways.

And to those who still can’t bear the thought of taking time off, remember Eastern’s First Law: Your last words will NOT be, “I wish I had spent more time in the office!”

Dr. Eastern practices dermatology and dermatologic surgery in Belleville, N.J. He is the author of numerous articles and textbook chapters, and is a longtime monthly columnist for Dermatology News.

References

References

Publications
Publications
Article Type
Display Headline
Sharpening the saw
Display Headline
Sharpening the saw
Sections
Article Source

PURLs Copyright

Inside the Article

From the Washington Office

Article Type
Changed
Wed, 01/02/2019 - 09:09
Display Headline
From the Washington Office

In November 2014, the Centers for Medicare & Medicaid Services finalized a policy that will transition all 10-day and 90-day global codes to 0-day global codes in 2017 and 2018, respectively.

As most surgeons will know, global codes include all necessary services normally furnished before, during, and after a surgical procedure. Approximately 4,200 of the more than 9,900 Current Procedural Terminology codes are 10-day or 90-day global codes. The CMS claims the transition is necessary, in part, to increase the accuracy of payment for these codes. Despite the fact that the policy for the 10-day codes will be put into effect in 2017, the CMS has yet to develop a methodology for making this transition.

Dr. Patrick V. Bailey

Prior to the release of the final rule, the ACS sent a detailed letter to the CMS asserting that the agency should postpone moving forward with this proposal until a comprehensive analysis of the effect on surgical patients and access to surgical care was completed. The ACS included recommendations on a number of issues that the CMS must resolve before moving forward with the proposed policy and stressed, above all, that the CMS should not make policy changes that infringe on surgeons’ ability to provide high-quality care to surgical patients. Despite the ACS regulatory advocacy efforts and those similar from other surgical and medical specialty groups, the CMS finalized the rule and continues to indicate that it plans to move forward.

During the lame duck session of Congress following the November election, a coalition of surgical groups led by the ACS drafted and provided to Congress legislative language the effect of which would be to preclude the CMS from moving forward with its plan to transition the 10-day and 90-day global codes to 0-day global codes.

The groups involved mounted an aggressive campaign, strongly advocating for the inclusion of the legislative language in the “CRomnibus” bill. Despite strong support from the Congressional “Doc Caucus” and other members of Congress, no language addressing transitioning of the global codes was included in the “CRomnibus” bill, which passed both chambers at the conclusion of the 113th Congress.

Now that the 114th Congress has begun, the ACS, working again in concert with the aforementioned coalition of other surgical and medical specialty groups, is taking a variety of strategic actions on both the legislative and regulatory fronts. Working with key members of Congress including Rep. Larry Bucshon, MD, FACS, Rep. Tom Price, MD, FACS, and Rep. Dan Benishek, MD, FACS, the ACS will continue to oppose implementation of the policy change by seeking congressional intervention to rescind the rule until such time as the CMS can ensure that the transition will not have a negative impact on patients and can be implemented in a way that accurately accounts for the care that surgeons provide.

Revised legislative language has been provided to Congress. Members of the ACS DAHP legislative affairs staff are engaged in daily advocacy efforts for inclusion of that language in legislation. ACS leaders and DAHP regulatory affairs staff have met with the CMS in an attempt to provide education concerning what is believed will be significant, negative impact of the policy on both patients and surgeons.

Fellows are encouraged to augment the efforts of the DAHP by personally contacting their senators and representatives to educate them about the following negative potential consequences the implementation of this policy would be expected to have:

1. Reduces patient access and quality of care. If 10-day and 90-day global codes are transitioned to 0-day global codes, patients will have a copay for the procedure and additional, separate copays for other services including each of the follow-up visits. Patients may also be responsible for separate payment of supplies and drugs necessary during postop visits currently bundled into the global payment, but not bundled into visit codes. This could considerably increase the financial burden on patients, or worse, discourage them from returning for follow-up care.

2. Undermines the current SGR legislation and other Medicare reform initiatives. The CMS initiatives for payment are all moving toward larger bundled payments. Deconstruction of the current payment structure for physicians is counterintuitive to the end goal of providing more comprehensive and coordinated care for patients.

3. Increases administrative burden. The administrative burden on surgical practices, the CMS, and its contractors will be significant. The American Medical Association estimates that eliminating the global package will result in 63 million additional claims per year to account for postsurgical evaluation and management services. This will add unnecessary costs to the claims processing system.

 

 

4. Obstructs clinical registry data collection and quality improvement. If patients forgo follow-up treatment or seek it from other providers, the policy would have a deleterious effect on surgeons’ ability to collect information on patient outcomes in clinical registries and undermine many meaningful quality improvement initiatives.

Staff members of the DC office are available to assist surgeons interested in contacting their individual senators and representatives to assist in the advocacy efforts relative to this policy. I can be reached by phone at 202-337-2701 or by e-mail at [email protected].

Until next month …

Dr. Bailey is a pediatric surgeon and Medical Director, Advocacy for the Division of Advocacy and Health Policy in the ACS offices in Washington, DC.

References

Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

In November 2014, the Centers for Medicare & Medicaid Services finalized a policy that will transition all 10-day and 90-day global codes to 0-day global codes in 2017 and 2018, respectively.

As most surgeons will know, global codes include all necessary services normally furnished before, during, and after a surgical procedure. Approximately 4,200 of the more than 9,900 Current Procedural Terminology codes are 10-day or 90-day global codes. The CMS claims the transition is necessary, in part, to increase the accuracy of payment for these codes. Despite the fact that the policy for the 10-day codes will be put into effect in 2017, the CMS has yet to develop a methodology for making this transition.

Dr. Patrick V. Bailey

Prior to the release of the final rule, the ACS sent a detailed letter to the CMS asserting that the agency should postpone moving forward with this proposal until a comprehensive analysis of the effect on surgical patients and access to surgical care was completed. The ACS included recommendations on a number of issues that the CMS must resolve before moving forward with the proposed policy and stressed, above all, that the CMS should not make policy changes that infringe on surgeons’ ability to provide high-quality care to surgical patients. Despite the ACS regulatory advocacy efforts and those similar from other surgical and medical specialty groups, the CMS finalized the rule and continues to indicate that it plans to move forward.

During the lame duck session of Congress following the November election, a coalition of surgical groups led by the ACS drafted and provided to Congress legislative language the effect of which would be to preclude the CMS from moving forward with its plan to transition the 10-day and 90-day global codes to 0-day global codes.

The groups involved mounted an aggressive campaign, strongly advocating for the inclusion of the legislative language in the “CRomnibus” bill. Despite strong support from the Congressional “Doc Caucus” and other members of Congress, no language addressing transitioning of the global codes was included in the “CRomnibus” bill, which passed both chambers at the conclusion of the 113th Congress.

Now that the 114th Congress has begun, the ACS, working again in concert with the aforementioned coalition of other surgical and medical specialty groups, is taking a variety of strategic actions on both the legislative and regulatory fronts. Working with key members of Congress including Rep. Larry Bucshon, MD, FACS, Rep. Tom Price, MD, FACS, and Rep. Dan Benishek, MD, FACS, the ACS will continue to oppose implementation of the policy change by seeking congressional intervention to rescind the rule until such time as the CMS can ensure that the transition will not have a negative impact on patients and can be implemented in a way that accurately accounts for the care that surgeons provide.

Revised legislative language has been provided to Congress. Members of the ACS DAHP legislative affairs staff are engaged in daily advocacy efforts for inclusion of that language in legislation. ACS leaders and DAHP regulatory affairs staff have met with the CMS in an attempt to provide education concerning what is believed will be significant, negative impact of the policy on both patients and surgeons.

Fellows are encouraged to augment the efforts of the DAHP by personally contacting their senators and representatives to educate them about the following negative potential consequences the implementation of this policy would be expected to have:

1. Reduces patient access and quality of care. If 10-day and 90-day global codes are transitioned to 0-day global codes, patients will have a copay for the procedure and additional, separate copays for other services including each of the follow-up visits. Patients may also be responsible for separate payment of supplies and drugs necessary during postop visits currently bundled into the global payment, but not bundled into visit codes. This could considerably increase the financial burden on patients, or worse, discourage them from returning for follow-up care.

2. Undermines the current SGR legislation and other Medicare reform initiatives. The CMS initiatives for payment are all moving toward larger bundled payments. Deconstruction of the current payment structure for physicians is counterintuitive to the end goal of providing more comprehensive and coordinated care for patients.

3. Increases administrative burden. The administrative burden on surgical practices, the CMS, and its contractors will be significant. The American Medical Association estimates that eliminating the global package will result in 63 million additional claims per year to account for postsurgical evaluation and management services. This will add unnecessary costs to the claims processing system.

 

 

4. Obstructs clinical registry data collection and quality improvement. If patients forgo follow-up treatment or seek it from other providers, the policy would have a deleterious effect on surgeons’ ability to collect information on patient outcomes in clinical registries and undermine many meaningful quality improvement initiatives.

Staff members of the DC office are available to assist surgeons interested in contacting their individual senators and representatives to assist in the advocacy efforts relative to this policy. I can be reached by phone at 202-337-2701 or by e-mail at [email protected].

Until next month …

Dr. Bailey is a pediatric surgeon and Medical Director, Advocacy for the Division of Advocacy and Health Policy in the ACS offices in Washington, DC.

In November 2014, the Centers for Medicare & Medicaid Services finalized a policy that will transition all 10-day and 90-day global codes to 0-day global codes in 2017 and 2018, respectively.

As most surgeons will know, global codes include all necessary services normally furnished before, during, and after a surgical procedure. Approximately 4,200 of the more than 9,900 Current Procedural Terminology codes are 10-day or 90-day global codes. The CMS claims the transition is necessary, in part, to increase the accuracy of payment for these codes. Despite the fact that the policy for the 10-day codes will be put into effect in 2017, the CMS has yet to develop a methodology for making this transition.

Dr. Patrick V. Bailey

Prior to the release of the final rule, the ACS sent a detailed letter to the CMS asserting that the agency should postpone moving forward with this proposal until a comprehensive analysis of the effect on surgical patients and access to surgical care was completed. The ACS included recommendations on a number of issues that the CMS must resolve before moving forward with the proposed policy and stressed, above all, that the CMS should not make policy changes that infringe on surgeons’ ability to provide high-quality care to surgical patients. Despite the ACS regulatory advocacy efforts and those similar from other surgical and medical specialty groups, the CMS finalized the rule and continues to indicate that it plans to move forward.

During the lame duck session of Congress following the November election, a coalition of surgical groups led by the ACS drafted and provided to Congress legislative language the effect of which would be to preclude the CMS from moving forward with its plan to transition the 10-day and 90-day global codes to 0-day global codes.

The groups involved mounted an aggressive campaign, strongly advocating for the inclusion of the legislative language in the “CRomnibus” bill. Despite strong support from the Congressional “Doc Caucus” and other members of Congress, no language addressing transitioning of the global codes was included in the “CRomnibus” bill, which passed both chambers at the conclusion of the 113th Congress.

Now that the 114th Congress has begun, the ACS, working again in concert with the aforementioned coalition of other surgical and medical specialty groups, is taking a variety of strategic actions on both the legislative and regulatory fronts. Working with key members of Congress including Rep. Larry Bucshon, MD, FACS, Rep. Tom Price, MD, FACS, and Rep. Dan Benishek, MD, FACS, the ACS will continue to oppose implementation of the policy change by seeking congressional intervention to rescind the rule until such time as the CMS can ensure that the transition will not have a negative impact on patients and can be implemented in a way that accurately accounts for the care that surgeons provide.

Revised legislative language has been provided to Congress. Members of the ACS DAHP legislative affairs staff are engaged in daily advocacy efforts for inclusion of that language in legislation. ACS leaders and DAHP regulatory affairs staff have met with the CMS in an attempt to provide education concerning what is believed will be significant, negative impact of the policy on both patients and surgeons.

Fellows are encouraged to augment the efforts of the DAHP by personally contacting their senators and representatives to educate them about the following negative potential consequences the implementation of this policy would be expected to have:

1. Reduces patient access and quality of care. If 10-day and 90-day global codes are transitioned to 0-day global codes, patients will have a copay for the procedure and additional, separate copays for other services including each of the follow-up visits. Patients may also be responsible for separate payment of supplies and drugs necessary during postop visits currently bundled into the global payment, but not bundled into visit codes. This could considerably increase the financial burden on patients, or worse, discourage them from returning for follow-up care.

2. Undermines the current SGR legislation and other Medicare reform initiatives. The CMS initiatives for payment are all moving toward larger bundled payments. Deconstruction of the current payment structure for physicians is counterintuitive to the end goal of providing more comprehensive and coordinated care for patients.

3. Increases administrative burden. The administrative burden on surgical practices, the CMS, and its contractors will be significant. The American Medical Association estimates that eliminating the global package will result in 63 million additional claims per year to account for postsurgical evaluation and management services. This will add unnecessary costs to the claims processing system.

 

 

4. Obstructs clinical registry data collection and quality improvement. If patients forgo follow-up treatment or seek it from other providers, the policy would have a deleterious effect on surgeons’ ability to collect information on patient outcomes in clinical registries and undermine many meaningful quality improvement initiatives.

Staff members of the DC office are available to assist surgeons interested in contacting their individual senators and representatives to assist in the advocacy efforts relative to this policy. I can be reached by phone at 202-337-2701 or by e-mail at [email protected].

Until next month …

Dr. Bailey is a pediatric surgeon and Medical Director, Advocacy for the Division of Advocacy and Health Policy in the ACS offices in Washington, DC.

References

References

Publications
Publications
Article Type
Display Headline
From the Washington Office
Display Headline
From the Washington Office
Sections
Article Source

PURLs Copyright

Inside the Article

Practicing surgery and having a life

Article Type
Changed
Wed, 01/02/2019 - 09:09
Display Headline
Practicing surgery and having a life

For those who have chosen the surgeon’s path, finding a sustainable work/life balance is challenging. For surgeons with young families and spousal responsibilities, achieving that balance may seem like an unattainable goal. As a rural surgeon with a spouse and children, I am here to say that rural practice has many benefits to those who love their work and also want a balanced life. I recommend that young surgeons, women in particular, consider this path for both the professional and personal advantages it offers.

I always tell the medical students that rotate with me, “When it is 4 o’clock in the morning and you forgot to go home ... be that.” That is to say, whatever rotation they are on when they have that feeling, that is the specialty they should choose. That was us when it came to surgery. When we were students going through surgical rotations we could not get enough. We wanted to see everything, do everything, and we didn’t want to miss anything. Many of our colleagues recommended against choosing surgery. We were told, “You’ll never have a life or a family;” “Your life will be horrible,” etc.

Dr. Susan Long

Now, many years later, I still love what I do as a surgeon. But I also love the other half of my life. I chose to practice rural surgery because I sensed that a balanced life would be possible in the rural setting. So I offer the following 10 tips for young surgeons who might be considering a rural practice:

1. Pick a good small town

Sit down and write out a list of all the things you want in a small town. My list, of course, will be different from your list but most importantly, make the list! It is no use taking a job in rural Colorado if you hate to hunt and fish. Consider the town and the job equally. For women surgeons, you may want to look for a place where there are women in upper administrative roles and other female physicians on staff. All small towns are definitely not alike and if you pick one for the hospital or the job without considering your surroundings, you will not likely be happy.

2. Don’t commute

Some people take a job in a small town or a rural setting but choose to live 30 miles away in the next larger town. I suggest living in the town you practice in. If at all possible, live close to the hospital. Every minute that you spend on the road is a minute away from your family. Living far away makes that 2 a.m. call from the ER that much more painful. You also miss out on the opportunity to become a real part of your community.

3. Choose the right partner

Small town physicians are tough to keep. Rural practice turnover is high. One of the most common reasons I hear for why a physician has left the area is because his or her spouse wasn’t happy. No matter how appealing the job seems, no matter how much bonus money they offer, no matter how great the hospital appears, if your spouse doesn’t like it there, you’ll be leaving. You may love your job and back country camping every weekend, but if your spouse pines for Whole Foods and the opera, you will be moving on eventually.

A large part of rural life revolves around events in the school system, and even if you have no young children of your own, it is helpful to make an effort to attend some of these events, if only to support your neighbor’s kids. It goes a long way to establish you as someone who is involved in the community and who cares. Remember, it is the mothers young and old who make many of the health care decisions for their families. Volunteer for events or get involved in the science program at the high school. You may find that you are a unique role model for teenagers in your community.

4. Choose the right partners

Rural general surgery is challenging enough without having to compete with those around you. Surgery in the small town setting becomes infinitely more pleasant when you have good partners. Is the practice set up to help and support each partner, or are you pitted against one another, competing for RVUs? Would your partners tolerate covering your call for 3 months of maternity leave or would this cause resentment? Look for a practice where the surgeons work together and cover for each other, and your small town life will be greatly enhanced.

 

 

5. Live within your means

A small town surgical practice can make for a very comfortable life. The cost of living is less, which means that your money goes further, with more left over for expenses such as saving for your kids’ college education. In addition, when you live in rural America, you won’t likely feel pressured to join the super expensive country club, send your kids to an expensive school, or drive a six-figure car. Although we may not make quite as much as the big city folk, when you account for the cost of living, rural surgeons do quite well.

6. Hire help

My husband is a firefighter, and at one point early in our marriage he was working night shift. With me on call and small children at home, that presented somewhat of a problem. But we solved it with a live-in nanny. Some people say, “I don’t want someone else raising my children,” and then they spend all their free time washing baby’s laundry and cleaning house instead of playing with the baby and having family meals and other family time together. How you utilize a nanny or any other help you hire is determined by you. But the idea is to hire help to do the mundane things so that you can do the fun things.

 7. Learn to charm a rock

Small towns can be tough. Make one mistake, make one person angry, and before you eat your breakfast the next morning, the whole town knows about it. A very wise mentor of mine once said, “You catch more flies with honey.” Of course, he was absolutely right. When we work in bigger places, we tend to become numb to our own behavior because outbursts and conflicts are so common that our own little outbursts get lost in the mix. Such is not the case in a small town.

In rural America, people stop their cars to let you pull out. This can be very shocking when you come from New York and your first thought is …am I being carjacked? In a rural town, if you walk around with a Band-Aid on your face, every single person you pass on the street will ask if you are ok. It teaches you to treat other people well, even if you are having an absolutely terrible day. You can’t get away with taking your mood out on other people in a small town.

One very nice thing about working in a rural community is that people are grateful and have a very long memory for whatever you’ve done for them. Whether you’ve cured their colon cancer or removed a lipoma, they will stop you on the street to thank you or tell their friends for years afterward about how wonderful you were.

8. Get a hobby

Although life as a small town general surgeon can seem like a 24/7 occupation, careful time management and household support can create space for a hobby. And you need one. No matter how much we all love surgery, it is essential that we cultivate the ability to leave it be for a time here and there. A hobby (preferably one that helps alleviate stress) can help stave off burnout.

9. Don’t forget to sleep

This much-neglected survival tip is so important. We all have to be on call, some more than others. But most of us also have nights where we are not on call. These should not be the nights where we stay up until 3 a.m. watching every episode of the latest Netflix series. You must resist that temptation. The older you get, the harder it is to recover from a night out operating.

10. Never forget the 4 a.m. feeling

So you may learn to adjust to the small town and then to love it fiercely and protectively. You may even buy your own cow once a year or join a shooting range. You may learn to discuss the fall elk hunt, ice fishing, ranching, and the best place to buy ammunition with your patients. You walk through the hospital and you know every single person you pass in the hallway as well as their kids.

Let us never forget why we chose to be surgeons. Most of us would weather any challenge to continue to do what we love. And choosing a rural practice is one way to practice surgery and also achieve a satisfying work/life balance.

Dr. Long is an ACS Fellow and a general surgeon in rural West Virginia. She is the mother of five and an ironman triathlete. She is currently preparing for her 18th surgical mission trip to Central America in April. Dr. Justine Gavagan and Dr. Catherine O’Connor contributed to this article.

References

Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

For those who have chosen the surgeon’s path, finding a sustainable work/life balance is challenging. For surgeons with young families and spousal responsibilities, achieving that balance may seem like an unattainable goal. As a rural surgeon with a spouse and children, I am here to say that rural practice has many benefits to those who love their work and also want a balanced life. I recommend that young surgeons, women in particular, consider this path for both the professional and personal advantages it offers.

I always tell the medical students that rotate with me, “When it is 4 o’clock in the morning and you forgot to go home ... be that.” That is to say, whatever rotation they are on when they have that feeling, that is the specialty they should choose. That was us when it came to surgery. When we were students going through surgical rotations we could not get enough. We wanted to see everything, do everything, and we didn’t want to miss anything. Many of our colleagues recommended against choosing surgery. We were told, “You’ll never have a life or a family;” “Your life will be horrible,” etc.

Dr. Susan Long

Now, many years later, I still love what I do as a surgeon. But I also love the other half of my life. I chose to practice rural surgery because I sensed that a balanced life would be possible in the rural setting. So I offer the following 10 tips for young surgeons who might be considering a rural practice:

1. Pick a good small town

Sit down and write out a list of all the things you want in a small town. My list, of course, will be different from your list but most importantly, make the list! It is no use taking a job in rural Colorado if you hate to hunt and fish. Consider the town and the job equally. For women surgeons, you may want to look for a place where there are women in upper administrative roles and other female physicians on staff. All small towns are definitely not alike and if you pick one for the hospital or the job without considering your surroundings, you will not likely be happy.

2. Don’t commute

Some people take a job in a small town or a rural setting but choose to live 30 miles away in the next larger town. I suggest living in the town you practice in. If at all possible, live close to the hospital. Every minute that you spend on the road is a minute away from your family. Living far away makes that 2 a.m. call from the ER that much more painful. You also miss out on the opportunity to become a real part of your community.

3. Choose the right partner

Small town physicians are tough to keep. Rural practice turnover is high. One of the most common reasons I hear for why a physician has left the area is because his or her spouse wasn’t happy. No matter how appealing the job seems, no matter how much bonus money they offer, no matter how great the hospital appears, if your spouse doesn’t like it there, you’ll be leaving. You may love your job and back country camping every weekend, but if your spouse pines for Whole Foods and the opera, you will be moving on eventually.

A large part of rural life revolves around events in the school system, and even if you have no young children of your own, it is helpful to make an effort to attend some of these events, if only to support your neighbor’s kids. It goes a long way to establish you as someone who is involved in the community and who cares. Remember, it is the mothers young and old who make many of the health care decisions for their families. Volunteer for events or get involved in the science program at the high school. You may find that you are a unique role model for teenagers in your community.

4. Choose the right partners

Rural general surgery is challenging enough without having to compete with those around you. Surgery in the small town setting becomes infinitely more pleasant when you have good partners. Is the practice set up to help and support each partner, or are you pitted against one another, competing for RVUs? Would your partners tolerate covering your call for 3 months of maternity leave or would this cause resentment? Look for a practice where the surgeons work together and cover for each other, and your small town life will be greatly enhanced.

 

 

5. Live within your means

A small town surgical practice can make for a very comfortable life. The cost of living is less, which means that your money goes further, with more left over for expenses such as saving for your kids’ college education. In addition, when you live in rural America, you won’t likely feel pressured to join the super expensive country club, send your kids to an expensive school, or drive a six-figure car. Although we may not make quite as much as the big city folk, when you account for the cost of living, rural surgeons do quite well.

6. Hire help

My husband is a firefighter, and at one point early in our marriage he was working night shift. With me on call and small children at home, that presented somewhat of a problem. But we solved it with a live-in nanny. Some people say, “I don’t want someone else raising my children,” and then they spend all their free time washing baby’s laundry and cleaning house instead of playing with the baby and having family meals and other family time together. How you utilize a nanny or any other help you hire is determined by you. But the idea is to hire help to do the mundane things so that you can do the fun things.

 7. Learn to charm a rock

Small towns can be tough. Make one mistake, make one person angry, and before you eat your breakfast the next morning, the whole town knows about it. A very wise mentor of mine once said, “You catch more flies with honey.” Of course, he was absolutely right. When we work in bigger places, we tend to become numb to our own behavior because outbursts and conflicts are so common that our own little outbursts get lost in the mix. Such is not the case in a small town.

In rural America, people stop their cars to let you pull out. This can be very shocking when you come from New York and your first thought is …am I being carjacked? In a rural town, if you walk around with a Band-Aid on your face, every single person you pass on the street will ask if you are ok. It teaches you to treat other people well, even if you are having an absolutely terrible day. You can’t get away with taking your mood out on other people in a small town.

One very nice thing about working in a rural community is that people are grateful and have a very long memory for whatever you’ve done for them. Whether you’ve cured their colon cancer or removed a lipoma, they will stop you on the street to thank you or tell their friends for years afterward about how wonderful you were.

8. Get a hobby

Although life as a small town general surgeon can seem like a 24/7 occupation, careful time management and household support can create space for a hobby. And you need one. No matter how much we all love surgery, it is essential that we cultivate the ability to leave it be for a time here and there. A hobby (preferably one that helps alleviate stress) can help stave off burnout.

9. Don’t forget to sleep

This much-neglected survival tip is so important. We all have to be on call, some more than others. But most of us also have nights where we are not on call. These should not be the nights where we stay up until 3 a.m. watching every episode of the latest Netflix series. You must resist that temptation. The older you get, the harder it is to recover from a night out operating.

10. Never forget the 4 a.m. feeling

So you may learn to adjust to the small town and then to love it fiercely and protectively. You may even buy your own cow once a year or join a shooting range. You may learn to discuss the fall elk hunt, ice fishing, ranching, and the best place to buy ammunition with your patients. You walk through the hospital and you know every single person you pass in the hallway as well as their kids.

Let us never forget why we chose to be surgeons. Most of us would weather any challenge to continue to do what we love. And choosing a rural practice is one way to practice surgery and also achieve a satisfying work/life balance.

Dr. Long is an ACS Fellow and a general surgeon in rural West Virginia. She is the mother of five and an ironman triathlete. She is currently preparing for her 18th surgical mission trip to Central America in April. Dr. Justine Gavagan and Dr. Catherine O’Connor contributed to this article.

For those who have chosen the surgeon’s path, finding a sustainable work/life balance is challenging. For surgeons with young families and spousal responsibilities, achieving that balance may seem like an unattainable goal. As a rural surgeon with a spouse and children, I am here to say that rural practice has many benefits to those who love their work and also want a balanced life. I recommend that young surgeons, women in particular, consider this path for both the professional and personal advantages it offers.

I always tell the medical students that rotate with me, “When it is 4 o’clock in the morning and you forgot to go home ... be that.” That is to say, whatever rotation they are on when they have that feeling, that is the specialty they should choose. That was us when it came to surgery. When we were students going through surgical rotations we could not get enough. We wanted to see everything, do everything, and we didn’t want to miss anything. Many of our colleagues recommended against choosing surgery. We were told, “You’ll never have a life or a family;” “Your life will be horrible,” etc.

Dr. Susan Long

Now, many years later, I still love what I do as a surgeon. But I also love the other half of my life. I chose to practice rural surgery because I sensed that a balanced life would be possible in the rural setting. So I offer the following 10 tips for young surgeons who might be considering a rural practice:

1. Pick a good small town

Sit down and write out a list of all the things you want in a small town. My list, of course, will be different from your list but most importantly, make the list! It is no use taking a job in rural Colorado if you hate to hunt and fish. Consider the town and the job equally. For women surgeons, you may want to look for a place where there are women in upper administrative roles and other female physicians on staff. All small towns are definitely not alike and if you pick one for the hospital or the job without considering your surroundings, you will not likely be happy.

2. Don’t commute

Some people take a job in a small town or a rural setting but choose to live 30 miles away in the next larger town. I suggest living in the town you practice in. If at all possible, live close to the hospital. Every minute that you spend on the road is a minute away from your family. Living far away makes that 2 a.m. call from the ER that much more painful. You also miss out on the opportunity to become a real part of your community.

3. Choose the right partner

Small town physicians are tough to keep. Rural practice turnover is high. One of the most common reasons I hear for why a physician has left the area is because his or her spouse wasn’t happy. No matter how appealing the job seems, no matter how much bonus money they offer, no matter how great the hospital appears, if your spouse doesn’t like it there, you’ll be leaving. You may love your job and back country camping every weekend, but if your spouse pines for Whole Foods and the opera, you will be moving on eventually.

A large part of rural life revolves around events in the school system, and even if you have no young children of your own, it is helpful to make an effort to attend some of these events, if only to support your neighbor’s kids. It goes a long way to establish you as someone who is involved in the community and who cares. Remember, it is the mothers young and old who make many of the health care decisions for their families. Volunteer for events or get involved in the science program at the high school. You may find that you are a unique role model for teenagers in your community.

4. Choose the right partners

Rural general surgery is challenging enough without having to compete with those around you. Surgery in the small town setting becomes infinitely more pleasant when you have good partners. Is the practice set up to help and support each partner, or are you pitted against one another, competing for RVUs? Would your partners tolerate covering your call for 3 months of maternity leave or would this cause resentment? Look for a practice where the surgeons work together and cover for each other, and your small town life will be greatly enhanced.

 

 

5. Live within your means

A small town surgical practice can make for a very comfortable life. The cost of living is less, which means that your money goes further, with more left over for expenses such as saving for your kids’ college education. In addition, when you live in rural America, you won’t likely feel pressured to join the super expensive country club, send your kids to an expensive school, or drive a six-figure car. Although we may not make quite as much as the big city folk, when you account for the cost of living, rural surgeons do quite well.

6. Hire help

My husband is a firefighter, and at one point early in our marriage he was working night shift. With me on call and small children at home, that presented somewhat of a problem. But we solved it with a live-in nanny. Some people say, “I don’t want someone else raising my children,” and then they spend all their free time washing baby’s laundry and cleaning house instead of playing with the baby and having family meals and other family time together. How you utilize a nanny or any other help you hire is determined by you. But the idea is to hire help to do the mundane things so that you can do the fun things.

 7. Learn to charm a rock

Small towns can be tough. Make one mistake, make one person angry, and before you eat your breakfast the next morning, the whole town knows about it. A very wise mentor of mine once said, “You catch more flies with honey.” Of course, he was absolutely right. When we work in bigger places, we tend to become numb to our own behavior because outbursts and conflicts are so common that our own little outbursts get lost in the mix. Such is not the case in a small town.

In rural America, people stop their cars to let you pull out. This can be very shocking when you come from New York and your first thought is …am I being carjacked? In a rural town, if you walk around with a Band-Aid on your face, every single person you pass on the street will ask if you are ok. It teaches you to treat other people well, even if you are having an absolutely terrible day. You can’t get away with taking your mood out on other people in a small town.

One very nice thing about working in a rural community is that people are grateful and have a very long memory for whatever you’ve done for them. Whether you’ve cured their colon cancer or removed a lipoma, they will stop you on the street to thank you or tell their friends for years afterward about how wonderful you were.

8. Get a hobby

Although life as a small town general surgeon can seem like a 24/7 occupation, careful time management and household support can create space for a hobby. And you need one. No matter how much we all love surgery, it is essential that we cultivate the ability to leave it be for a time here and there. A hobby (preferably one that helps alleviate stress) can help stave off burnout.

9. Don’t forget to sleep

This much-neglected survival tip is so important. We all have to be on call, some more than others. But most of us also have nights where we are not on call. These should not be the nights where we stay up until 3 a.m. watching every episode of the latest Netflix series. You must resist that temptation. The older you get, the harder it is to recover from a night out operating.

10. Never forget the 4 a.m. feeling

So you may learn to adjust to the small town and then to love it fiercely and protectively. You may even buy your own cow once a year or join a shooting range. You may learn to discuss the fall elk hunt, ice fishing, ranching, and the best place to buy ammunition with your patients. You walk through the hospital and you know every single person you pass in the hallway as well as their kids.

Let us never forget why we chose to be surgeons. Most of us would weather any challenge to continue to do what we love. And choosing a rural practice is one way to practice surgery and also achieve a satisfying work/life balance.

Dr. Long is an ACS Fellow and a general surgeon in rural West Virginia. She is the mother of five and an ironman triathlete. She is currently preparing for her 18th surgical mission trip to Central America in April. Dr. Justine Gavagan and Dr. Catherine O’Connor contributed to this article.

References

References

Publications
Publications
Article Type
Display Headline
Practicing surgery and having a life
Display Headline
Practicing surgery and having a life
Sections
Article Source

PURLs Copyright

Inside the Article

Only as good as the prep

Article Type
Changed
Mon, 05/06/2019 - 12:13
Display Headline
Only as good as the prep

In the realm of screening routinely offered to our patients in primary care, colon cancer screening stands with cervical cancer screening with a grade A recommendation from the U.S. Preventive Services Task Force. As such, our systems have been set up to gently remind us of colon cancer screening when it is due. If your practice is like mine, it has been almost exclusively colonoscopy. As such, I hear a lot of patient complaints about the colonoscopy prep.

Recently, one of our patients had uncontrolled vomiting with one of the commonly used polyethylene glycol (PEG) 3350 preparations. Many of us may have been aware of the Miralax and Gatorade (M-G) colon prep, and I considered recommending it to my patient. But is it just as good?

Dr. Sameer Siddique of the University of Missouri, Columbia, and colleagues published a systematic review evaluating the comparability of the M-G prep (238-255 g in 1.9 L) to PEG (3.8-4 L) (Am. J. Gastroenterol. 2014;109:1566-74).

The investigators identified five articles and observed that the M-G prep was associated with significantly fewer satisfactory bowel preparations, compared with PEG (odds ratio, 0.65; 95% confidence interval, 0.43-0.98; P = .04). In a subgroup analysis, split-dose M-G was inferior to split-dose PEG in the number of satisfactory preparations.

Patients, however, had a greater willingness to repeat the preparation (OR, 7.32; 95% CI, 4.88-10.98; P <.01). No significant differences were observed with polyp detection or in side effects such as nausea, cramping, or bloating.

The study authors point out that the dose of Miralax in the M-G prep is not FDA approved (because it is 15 times higher than the dose for constipation), and that the solution is hypotonic and can potentially cause hyponatremia. Furthermore, the cost of a colonoscopy ranges from $600 to more than $5,400. At those prices, patient agreeableness to repeat the test does not mean the health care system can bear a deluge of re-do’s.

Remember that split-dose PEG (one half the day before and one half the day of) has been shown to be superior to the night-before preparation, and it can increase tolerability. If a patient has time to get the job done the day of the colonoscopy, maybe this is the way to go.

Dr. Ebbert is professor of medicine, a general internist at the Mayo Clinic in Rochester, Minn., and a diplomate of the American Board of Addiction Medicine. The opinions expressed are those of the author and do not necessarily represent the views and opinions of the Mayo Clinic. The opinions expressed in this article should not be used to diagnose or treat any medical condition, nor should they be used as a substitute for medical advice from a qualified, board-certified practicing clinician.

References

Author and Disclosure Information

Publications
Topics
Legacy Keywords
colonoscopy, colon cancer, screening
Sections
Author and Disclosure Information

Author and Disclosure Information

In the realm of screening routinely offered to our patients in primary care, colon cancer screening stands with cervical cancer screening with a grade A recommendation from the U.S. Preventive Services Task Force. As such, our systems have been set up to gently remind us of colon cancer screening when it is due. If your practice is like mine, it has been almost exclusively colonoscopy. As such, I hear a lot of patient complaints about the colonoscopy prep.

Recently, one of our patients had uncontrolled vomiting with one of the commonly used polyethylene glycol (PEG) 3350 preparations. Many of us may have been aware of the Miralax and Gatorade (M-G) colon prep, and I considered recommending it to my patient. But is it just as good?

Dr. Sameer Siddique of the University of Missouri, Columbia, and colleagues published a systematic review evaluating the comparability of the M-G prep (238-255 g in 1.9 L) to PEG (3.8-4 L) (Am. J. Gastroenterol. 2014;109:1566-74).

The investigators identified five articles and observed that the M-G prep was associated with significantly fewer satisfactory bowel preparations, compared with PEG (odds ratio, 0.65; 95% confidence interval, 0.43-0.98; P = .04). In a subgroup analysis, split-dose M-G was inferior to split-dose PEG in the number of satisfactory preparations.

Patients, however, had a greater willingness to repeat the preparation (OR, 7.32; 95% CI, 4.88-10.98; P <.01). No significant differences were observed with polyp detection or in side effects such as nausea, cramping, or bloating.

The study authors point out that the dose of Miralax in the M-G prep is not FDA approved (because it is 15 times higher than the dose for constipation), and that the solution is hypotonic and can potentially cause hyponatremia. Furthermore, the cost of a colonoscopy ranges from $600 to more than $5,400. At those prices, patient agreeableness to repeat the test does not mean the health care system can bear a deluge of re-do’s.

Remember that split-dose PEG (one half the day before and one half the day of) has been shown to be superior to the night-before preparation, and it can increase tolerability. If a patient has time to get the job done the day of the colonoscopy, maybe this is the way to go.

Dr. Ebbert is professor of medicine, a general internist at the Mayo Clinic in Rochester, Minn., and a diplomate of the American Board of Addiction Medicine. The opinions expressed are those of the author and do not necessarily represent the views and opinions of the Mayo Clinic. The opinions expressed in this article should not be used to diagnose or treat any medical condition, nor should they be used as a substitute for medical advice from a qualified, board-certified practicing clinician.

In the realm of screening routinely offered to our patients in primary care, colon cancer screening stands with cervical cancer screening with a grade A recommendation from the U.S. Preventive Services Task Force. As such, our systems have been set up to gently remind us of colon cancer screening when it is due. If your practice is like mine, it has been almost exclusively colonoscopy. As such, I hear a lot of patient complaints about the colonoscopy prep.

Recently, one of our patients had uncontrolled vomiting with one of the commonly used polyethylene glycol (PEG) 3350 preparations. Many of us may have been aware of the Miralax and Gatorade (M-G) colon prep, and I considered recommending it to my patient. But is it just as good?

Dr. Sameer Siddique of the University of Missouri, Columbia, and colleagues published a systematic review evaluating the comparability of the M-G prep (238-255 g in 1.9 L) to PEG (3.8-4 L) (Am. J. Gastroenterol. 2014;109:1566-74).

The investigators identified five articles and observed that the M-G prep was associated with significantly fewer satisfactory bowel preparations, compared with PEG (odds ratio, 0.65; 95% confidence interval, 0.43-0.98; P = .04). In a subgroup analysis, split-dose M-G was inferior to split-dose PEG in the number of satisfactory preparations.

Patients, however, had a greater willingness to repeat the preparation (OR, 7.32; 95% CI, 4.88-10.98; P <.01). No significant differences were observed with polyp detection or in side effects such as nausea, cramping, or bloating.

The study authors point out that the dose of Miralax in the M-G prep is not FDA approved (because it is 15 times higher than the dose for constipation), and that the solution is hypotonic and can potentially cause hyponatremia. Furthermore, the cost of a colonoscopy ranges from $600 to more than $5,400. At those prices, patient agreeableness to repeat the test does not mean the health care system can bear a deluge of re-do’s.

Remember that split-dose PEG (one half the day before and one half the day of) has been shown to be superior to the night-before preparation, and it can increase tolerability. If a patient has time to get the job done the day of the colonoscopy, maybe this is the way to go.

Dr. Ebbert is professor of medicine, a general internist at the Mayo Clinic in Rochester, Minn., and a diplomate of the American Board of Addiction Medicine. The opinions expressed are those of the author and do not necessarily represent the views and opinions of the Mayo Clinic. The opinions expressed in this article should not be used to diagnose or treat any medical condition, nor should they be used as a substitute for medical advice from a qualified, board-certified practicing clinician.

References

References

Publications
Publications
Topics
Article Type
Display Headline
Only as good as the prep
Display Headline
Only as good as the prep
Legacy Keywords
colonoscopy, colon cancer, screening
Legacy Keywords
colonoscopy, colon cancer, screening
Sections
Article Source

PURLs Copyright

Inside the Article